| Year |
Title |
Altmetric |
| 2023
|
Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations.
Journal of Rheumatology.
50:438-450.
2023
|
|
| 2023
|
Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C).
Seminars in Arthritis and Rheumatism.
58.
2023
|
|
| 2022
|
Clustering Patients With Gout Based on Comorbidities and Biomarkers: A Cross-Sectional Study..
Journal of Rheumatology.
2022
|
|
| 2022
|
Association between the number of adopted implementation strategies and contextual determinants: a mixed-methods study.
BMC Health Services Research.
22.
2022
|
|
| 2022
|
Muscle transcriptomic circuits linked to periarticular physiology in end-stage osteoarthritis.
Physiological Genomics.
54:501-513.
2022
|
|
| 2022
|
NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study.
Virology Journal.
19.
2022
|
|
| 2022
|
Recommendations for the treatment of rheumatoid arthritis in Saudi Arabia: adolopment of the 2021 American College of Rheumatology guidelines.
BMC Rheumatology.
6.
2022
|
|
| 2022
|
The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
The Lancet. Healthy Longevity.
3:e754-e776.
2022
|
|
| 2022
|
Change in serum urate level with urate-lowering therapy initiation associates in the immediate term with patient-reported outcomes in people with gout.
Seminars in Arthritis and Rheumatism.
56.
2022
|
|
| 2022
|
Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction.
Arthritis Care and Research.
74:1649-1658.
2022
|
|
| 2022
|
Telemedicine in rheumatology care: A systematic review.
Seminars in Arthritis and Rheumatism.
56.
2022
|
|
| 2022
|
Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.
RMD Open.
8.
2022
|
|
| 2022
|
2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Journal of Arthroplasty.
37:1676-1683.
2022
|
|
| 2022
|
2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Arthritis Care and Research.
74:1399-1408.
2022
|
|
| 2022
|
2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Arthritis and Rheumatology.
74:1464-1473.
2022
|
|
| 2022
|
A Framework for the Development of Living Practice Guidelines in Health Care..
ACP journal club.
175:1154-1160.
2022
|
|
| 2022
|
Patient Empowerment Among Adults With Arthritis: The Case for Emotional Support.
Journal of Rheumatology.
49:948-955.
2022
|
|
| 2022
|
Response to: € Confunding by indication and ethnicity difference? Comment on € Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data'' by Hsu et al.
Annals of the Rheumatic Diseases.
81:E123.
2022
|
|
| 2022
|
Response to: € Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the artcile by Singh and Clevland' by Quills et al.
Annals of the Rheumatic Diseases.
81:E125.
2022
|
|
| 2022
|
Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendations.
Pain.
163:1006-1018.
2022
|
|
| 2022
|
Response to: 'Correspondence to "Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data' by Ma et al.
Annals of the Rheumatic Diseases.
81:E108.
2022
|
|
| 2022
|
The HOME Core outcome set for clinical trials of atopic dermatitis.
Journal of Allergy and Clinical Immunology.
149:1899-1911.
2022
|
|
| 2022
|
COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.
Lancet Rheumatology.
4:e237-e240.
2022
|
|
| 2022
|
Perioperative assessment of muscle inflammation susceptibility in patients with end-stage osteoarthritis.
Journal of Applied Physiology.
132:984-994.
2022
|
|
| 2022
|
Racial Differences in XO (Xanthine Oxidase) and Mitochondrial DNA Damage-Associated Molecular Patterns in Resistant Hypertension.
Hypertension.
79:775-784.
2022
|
|
| 2022
|
Telemedicine Use During the COVID-19 Pandemic by Resilient Rheumatology Providers: A National Veterans Affairs Follow-up Survey.
Journal of Rheumatology.
49:424-431.
2022
|
|
| 2022
|
Epidemiology and Outcomes of Alcohol Use Hospitalizations in People with Gout, Rheumatoid Arthritis, Fibromyalgia, Osteoarthritis, or Low Back Pain: A National US Study
2022
|
|
| 2022
|
Organizational context and the learning and change readiness climate for implementing an evidence-based shared decision-making aid in US rheumatology clinics
2022
|
|
| 2022
|
Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US.
JAMA Internal Medicine.
182:153-162.
2022
|
|
| 2022
|
Risks and Benefits of Janus Kinase Inhibitors in Rheumatoid Arthritis — Past, Present, and Future.
New England Journal of Medicine.
386:387-389.
2022
|
|
| 2022
|
Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials.
Lancet Rheumatology.
4:e53-e60.
2022
|
|
| 2022
|
Disease modification in gout: A qualitative study of gout expert rheumatologists.
Rheumatology Advances in Practice.
6.
2022
|
|
| 2022
|
Gout management and outcomes during established COVID-19 pandemic in 2020–2021: a cross-sectional Internet survey.
Therapeutic Advances in Musculoskeletal Disease.
14.
2022
|
|
| 2022
|
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative.
Lancet Rheumatology.
4:e33-e41.
2022
|
|
| 2022
|
Telemedicine including Video-Based Visits in Rheumatology in COVID-19 Pandemic: Not Yet Ideal
2022
|
|
| 2022
|
The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
2022
|
|
| 2022
|
Time trends in hospitalizations with anxiolytic, sedative, or hypnotic drug use disorder: a 17-year U.S. national study.
Journal of Addictive Diseases.
40:4-11.
2022
|
|
| 2022
|
Time-trends in hospitalizations with cannabis use disorder: A 17-year U.S. national study.
Substance Abuse.
43:408-414.
2022
|
|
| 2021
|
NSAID use and clinical outcomes in COVID-19 patients: A 38-center retrospective cohort study.
2021
|
|
| 2021
|
Epidemiology of hospitalizations with cocaine use disorder: A 17-year U.S. national study.
Journal of Psychiatric Research.
144:32-36.
2021
|
|
| 2021
|
Medicaid Payer Status, Higher Comorbidity, and Low Income Are Associated with Poorer Outcomes after Total Elbow Arthroplasty
2021
|
|
| 2021
|
Public health utility of cause of death data: applying empirical algorithms to improve data quality.
BMC Medical Informatics and Decision Making.
21.
2021
|
|
| 2021
|
Recent health-related quality of life, but not change, predicted mortality and healthcare utilization.
Journal of Clinical Epidemiology.
140:13-21.
2021
|
|
| 2021
|
SToRytelliing to Improve Disease outcomes in Gout (STRIDE-GO) in African American veterans with gout: a trial study protocol.
Trials.
22.
2021
|
|
| 2021
|
SToRytelling to Improve Disease outcomes in Gout (STRIDE-GO): a multicenter, randomized controlled trial in African American veterans with gout.
BMC Medicine.
19.
2021
|
|
| 2021
|
Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group.
Seminars in Arthritis and Rheumatism.
51:1378-1385.
2021
|
|
| 2021
|
“I wish it had a place to go”: a nominal group study of barriers to the effectiveness of non-surgical treatments for knee osteoarthritis inclusive of minority populations.
Arthritis Research and Therapy.
23.
2021
|
|
| 2021
|
Epidemiology of hospitalizations with amphetamine use disorder: A 17-year U.S. national cross-sectional study.
Asian Journal of Psychiatry.
65.
2021
|
|
| 2021
|
Higher Serum Urate Levels Are Associated With an Increased Risk for Sudden Cardiac Death.
Journal of Rheumatology.
48:1745-1753.
2021
|
|
| 2021
|
Letter to the editor: Cocaine use and cocaine use disorder: Revisiting epidemiology and clinical impact: Cocaine use disorder hospitalization burden, time-trends and outcomes.
Journal of Psychiatric Research.
143:467-468.
2021
|
|
| 2021
|
Fatal police violence by race and state in the USA, 1980–2019: a network meta-regression
2021
|
|
| 2021
|
Comment on: Dual-energy computed tomography versus ultrasound, alone or combined, for the diagnosis of gout: A prospective study of accuracy: Reply.
Rheumatology.
60:E372-E374.
2021
|
|
| 2021
|
Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group report.
Seminars in Arthritis and Rheumatism.
51:1108-1112.
2021
|
|
| 2021
|
Declining in-hospital mortality in vasculitis: A 17-year US national study.
European Journal of Rheumatology.
8:232-234.
2021
|
|
| 2021
|
Dual-energy computed tomography vs ultrasound, alone or combined, for the diagnosis of gout: A prospective study of accuracy.
Rheumatology.
60:4861-4867.
2021
|
|
| 2021
|
Epidemiology, Time Trends, and Outcomes of Serious Infections in Patients With Vasculitis: A Nineteen-Year National Study.
Arthritis Care and Research.
73:1544-1551.
2021
|
|
| 2021
|
Pop a pill or give myself a shot? Patient perspectives of disease-modifying anti-rheumatic drug choice for rheumatoid arthritis.
Revue du Rhumatisme.
88:362-368.
2021
|
|
| 2021
|
Cardiovascular safety of febuxostat
2021
|
|
| 2021
|
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.
RMD Open.
7.
2021
|
|
| 2021
|
Genetic correlations between traits associated with hyperuricemia, gout, and comorbidities.
European Journal of Human Genetics.
29:1438-1445.
2021
|
|
| 2021
|
The Patients' Perspective of Important Glucocorticoid Effects: A Nominal Group Study among Patients with Systemic Lupus Erythematosus and Myositis
2021
|
|
| 2021
|
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group.
Seminars in Arthritis and Rheumatism.
51:946-950.
2021
|
|
| 2021
|
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Arthritis Care and Research.
73:924-939.
2021
|
|
| 2021
|
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Arthritis and Rheumatology.
73:1108-1123.
2021
|
|
| 2021
|
Management of Rheumatic Diseases During the COVID-19 Pandemic: A National Veterans Affairs Survey of Rheumatologists.
Arthritis Care and Research.
73:998-1003.
2021
|
|
| 2021
|
Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.
PLoS Neglected Tropical Diseases.
15.
2021
|
|
| 2021
|
Time trends in in-hospital mortality reduction in vasculitis vs. non-vasculitis hospitalisations vary by patient sex and age.
Joint Bone Spine.
88.
2021
|
|
| 2021
|
Time-trends in cocaine, hallucinogen, amphetamine, and sedative/anxiolytic/hypnotic use disorder hospitalizations in rheumatic diseases: a national time-trends study.
Clinical Rheumatology.
40:3007-3014.
2021
|
|
| 2021
|
Comment on: Cannabis use assessment and its impact on pain in rheumatologic diseases: A systematic review and meta-analysis.
Rheumatology.
60:E222-E224.
2021
|
|
| 2021
|
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach.
Seminars in Arthritis and Rheumatism.
51:593-600.
2021
|
|
| 2021
|
Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working group.
Seminars in Arthritis and Rheumatism.
51:655-660.
2021
|
|
| 2021
|
Hospitalized infections in people with osteoarthritis: A national US study.
Journal of Rheumatology.
48:933-939.
2021
|
|
| 2021
|
OMERACT 2020: A virtual (R)evolution.
Seminars in Arthritis and Rheumatism.
51:588-592.
2021
|
|
| 2021
|
OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods study.
Seminars in Arthritis and Rheumatism.
51:601-606.
2021
|
|
| 2021
|
Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working group.
Seminars in Arthritis and Rheumatism.
51:650-654.
2021
|
|
| 2021
|
Serious Infections in Patients With Gout in the US: A National Study of Incidence, Time Trends, and Outcomes.
Arthritis Care and Research.
73:898-908.
2021
|
|
| 2021
|
Declining in-hospital mortality gap between systemic lupus erythematosus (SLE) and non-SLE hospitalisations: A national study.
Annals of the Rheumatic Diseases.
80:672-675.
2021
|
|
| 2021
|
Factors associated with healthcare utilization and mortality in alcohol use disorder hospitalization.
Drug and Alcohol Dependence.
222.
2021
|
|
| 2021
|
Time trends in opioid use disorder hospitalizations in gout, rheumatoid arthritis, fibromyalgia, osteoarthritis, and low back pain.
Journal of Rheumatology.
48:775-784.
2021
|
|
| 2021
|
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) common language definition of gout.
RMD Open.
7.
2021
|
|
| 2021
|
Applying evidence-based methods to the development and use of adverse outcome pathways
2021
|
|
| 2021
|
Hospitalized Infections in Lupus: A Nationwide Study of Types of Infections, Time Trends, Health Care Utilization, and In-Hospital Mortality.
Arthritis and Rheumatology.
73:617-630.
2021
|
|
| 2021
|
How do dietary interventions affect serum urate and gout?.
Nature Reviews Rheumatology.
17:191-192.
2021
|
|
| 2021
|
Driving Impairment following Vaporization of Cannabis.
Journal of the American Medical Association.
325:1225-1226.
2021
|
|
| 2021
|
Implementing the DEcision-Aid for Lupus (IDEAL): study protocol of a multi-site implementation trial with observational, case study design : Implementing the DEcision-Aid for Lupus..
Implementation Science Communications.
2:30.
2021
|
|
| 2021
|
In-hospital mortality reduction in systemic lupus erythematosus over 2 decades varied by patient sex and age.
Clinical Rheumatology.
40:1201-1203.
2021
|
|
| 2021
|
Polymyalgia Rheumatica Has Minimal Impact on Primary Total Knee or Hip Arthroplasty Outcomes
2021
|
|
| 2021
|
When has a knee or hip replacement failed? a patient perspective.
Journal of Rheumatology.
48:447-453.
2021
|
|
| 2021
|
Belimumab for systemic lupus erythematosus
2021
|
|
| 2021
|
Burden of Neurological Disorders across the US from 1990-2017: A Global Burden of Disease Study.
JAMA Neurology.
78:165-176.
2021
|
|
| 2021
|
Flare rate thresholds for patient assessment of disease activity states in Gout.
Journal of Rheumatology.
48:293-298.
2021
|
|
| 2021
|
Shared decision-making in gout treatment: a national study of rheumatology provider opinion and practice.
Clinical Rheumatology.
40:693-700.
2021
|
|
| 2021
|
Which factors predict discordance between a patient and physician on a gout flare?.
Rheumatology.
60:773-779.
2021
|
|
| 2021
|
Epidemiology of cardiac or orthopedic procedures in gout versus rheumatoid arthritis: a national time-trends study.
Therapeutic Advances in Musculoskeletal Disease.
13.
2021
|
|
| 2021
|
Epidemiology of hospitalizations with hallucinogen use disorder: a 17-year U.S. National study.
Journal of Addictive Diseases.
39:545-549.
2021
|
|
| 2021
|
Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis.
Therapeutic Advances in Musculoskeletal Disease.
13.
2021
|
|
| 2021
|
Important determinants of the patient choice between TNF- vs. non-TNF biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA).
Revue du Rhumatisme.
88:49-55.
2021
|
|
| 2021
|
Infection versus cardiovascular disease as leading causes of hospitalisations and associated mortality in vasculitis in the U.S.: A national study.
Clinical and Experimental Rheumatology.
39.
2021
|
|
| 2021
|
Pop a pill or give myself a shot? Patient perspectives of disease-modifying anti-rheumatic drug choice for rheumatoid arthritis.
Joint Bone Spine.
88.
2021
|
|
| 2021
|
Serious infections in Sjögren's syndrome patients: A national U.S. study.
Clinical and Experimental Rheumatology.
38:S47-S52.
2021
|
|
| 2021
|
The changing epidemiology of inpatient gout and associated mortality: A 17-year national study.
Rheumatology.
60:462-465.
2021
|
|
| 2020
|
Misconceived expectations: Patient reflections on the total knee replacement journey.
Musculoskeletal Care.
18:415-424.
2020
|
|
| 2020
|
Patient Perspectives on Gout and Gout Treatments: A Patient Panel Discussion That Informed the 2020 American College of Rheumatology Treatment Guideline.
ACR Open Rheumatology.
2:725-733.
2020
|
|
| 2020
|
Gender and Ethnic Inequities in Gout Burden and Management.
Rheumatic Disease Clinics of North America.
46:693-703.
2020
|
|
| 2020
|
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations.
Pain.
161:2446-2461.
2020
|
|
| 2020
|
Response to Letter to the Editor on “Assessment of a Satisfaction Measure for Use After Primary Total Joint Arthroplasty”.
Journal of Arthroplasty.
35:3418-3419.
2020
|
|
| 2020
|
Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study.
Clinical Rheumatology.
39:3427-3438.
2020
|
|
| 2020
|
Scope of outcomes in trials and observational studies of interventions targeting medication adherence in rheumatic conditions: A systematic review.
Journal of Rheumatology.
47:1565-1574.
2020
|
|
| 2020
|
Trends in Hospitalizations for Alcohol Use Disorder in the US From 1998 to 2016.
JAMA Network Open.
3:e2016580.
2020
|
|
| 2020
|
How systemic sclerosis affects healthcare use and complication rates after total hip arthroplasty.
Journal of Rheumatology.
47:1218-1223.
2020
|
|
| 2020
|
Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working group.
Seminars in Arthritis and Rheumatism.
50:719-727.
2020
|
|
| 2020
|
Patient-centered outcomes and key study procedure finalization in the pilot feasibility gout randomized trial: Comparative feasibility study in GOUt, CHerry extract versus diet modification (Mini-GOUCH)
2020
|
|
| 2020
|
Spondyloarthritis is associated with higher healthcare utilization and complication rates after primary total knee or total hip arthroplasty.
Clinical Rheumatology.
39:2345-2353.
2020
|
|
| 2020
|
The burden of skin and subcutaneous diseases in the United States from 1990 to 2017.
JAMA Dermatology.
156:874-881.
2020
|
|
| 2020
|
Sjogren's syndrome is associated with higher rate of non-home discharge after primary hip arthroplasty and higher transfusion rates after primary hip or knee arthroplasty: A U.S. cohort study.
BMC Musculoskeletal Disorders.
21.
2020
|
|
| 2020
|
Sjogren’s Syndrome is associated with higher healthcare utilization after primary hip, but not primary knee arthroplasty: A U.S. cohort study
2020
|
|
| 2020
|
Assessment of a Satisfaction Measure for Use After Primary Total Joint Arthroplasty.
Journal of Arthroplasty.
35:1792-1799.e4.
2020
|
|
| 2020
|
Important determinants of the patient choice between TNF- vs. non-TNF Biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA).
Joint Bone Spine.
87:307-313.
2020
|
|
| 2020
|
Serious infections in people with systemic sclerosis: A national US study.
Arthritis Research and Therapy.
22.
2020
|
|
| 2020
|
Patient, physiotherapist and surgeon endorsement of the core domain set for total hip and total knee replacement in Germany: A study protocol for an OMERACT initiative.
BMJ Open.
10.
2020
|
|
| 2020
|
Identifying Physician-perceived Barriers to Apragmatictreatment Trial Inrheumatoid Arthritis
2020
|
|
| 2020
|
Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17: Analysis for the Global Burden of Disease Study 2017
2020
|
|
| 2020
|
2020 American College of Rheumatology Guideline for the Management of Gout.
Arthritis Care and Research.
72:744-760.
2020
|
|
| 2020
|
2020 American College of Rheumatology Guideline for the Management of Gout.
Arthritis and Rheumatology.
72:879-895.
2020
|
|
| 2020
|
A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout
2020
|
|
| 2020
|
A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout.
2020
|
|
| 2020
|
Gout epidemiology and comorbidities.
Seminars in Arthritis and Rheumatism.
50:S11-S16.
2020
|
|
| 2020
|
Patient Perceptions of Gout Management Goals: A Cross-sectional Internet Survey
2020
|
|
| 2020
|
Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2020
|
|
| 2020
|
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017.
Lancet Gastroenterology and Hepatology.
5:582-597.
2020
|
|
| 2020
|
Allopurinol adherence and its predictors in gout: a national cohort study in US veterans.
Lancet Rheumatology.
2:e281-e291.
2020
|
|
| 2020
|
Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017.
Nature Medicine.
26:750-759.
2020
|
|
| 2020
|
Validation of the Hip Disability and Osteoarthritis Outcome Score and Knee Injury and Osteoarthritis Outcome Score Pain and Function Subscales for Use in Total Hip Replacement and Total Knee Replacement Clinical Trials.
Journal of Arthroplasty.
35:1200-1207.e4.
2020
|
|
| 2020
|
Serious Infections in People with Systemic sclerosis: A National U.S. Study
2020
|
|
| 2020
|
Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy.
Cochrane Database of Systematic Reviews.
2020.
2020
|
|
| 2020
|
Gout is associated with an increased risk for incident heart failure among older adults: The REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study.
Arthritis Research and Therapy.
22.
2020
|
|
| 2020
|
Hypersensitivity reactions with allopurinol and febuxostat: A study using the Medicare claims data.
Annals of the Rheumatic Diseases.
79:529-535.
2020
|
|
| 2020
|
Insurance Payer Type and Patient Income Are Associated with Outcomes after Total Shoulder Arthroplasty.
Journal of Rheumatology.
47:589-596.
2020
|
|
| 2020
|
Examining Timeliness of Total Knee Replacement among Patients with Knee Osteoarthritis in the U.S.: Results from the OAI and MOST Longitudinal Cohorts
2020
|
|
| 2020
|
Age, race, comorbidity, and insurance payer type are associated with outcomes after total ankle arthroplasty.
Clinical Rheumatology.
39:881-890.
2020
|
|
| 2020
|
Factors influencing the effectiveness of allopurinol in achieving and sustaining target serum urate in a US Veterans Affairs gout cohort.
Journal of Rheumatology.
47:449-460.
2020
|
|
| 2020
|
Polymyositis has minimal effect on primary total knee or hip arthroplasty outcomes.
Clinical Rheumatology.
39:823-830.
2020
|
|
| 2020
|
Socioeconomic status and healthcare access are associated with healthcare utilization after knee arthroplasty: A U.S. national cohort study.
Joint Bone Spine.
87:157-162.
2020
|
|
| 2020
|
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017.
Lancet Gastroenterology and Hepatology.
5:245-266.
2020
|
|
| 2020
|
The risk of Gougerot-Sjogren's syndrome in older adults with gout: A Medicare claims study.
Revue du Rhumatisme.
87:110-115.
2020
|
|
| 2020
|
Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2020
|
|
| 2020
|
Sjogren’s Syndrome is associated with higher healthcare utilization after primary hip, but not primary knee arthroplasty: A U.S. cohort study
2020
|
|
| 2020
|
Acute kidney injury after primary total hip arthroplasty: A risk multiplier for complication, mortality, and healthcare utilization.
Arthritis Research and Therapy.
22.
2020
|
|
| 2020
|
National U.S. Time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality.
PLoS One.
15.
2020
|
|
| 2020
|
Serious Infections in People with Scleroderma: A National U.S. Study
2020
|
|
| 2020
|
Patients' perspectives of outcomes after total knee and total hip arthroplasty: A nominal group study.
BMC Rheumatology.
4.
2020
|
|
| 2020
|
Mapping child growth failure across low- and middle-income countries.
Nature.
577:231-234.
2020
|
|
| 2020
|
Mapping disparities in education across low- and middle-income countries.
Nature.
577:235-238.
2020
|
|
| 2020
|
Acute kidney injury is associated with increased healthcare utilization, complications, and mortality after primary total knee arthroplasty.
Therapeutic Advances in Musculoskeletal Disease.
12.
2020
|
|
| 2020
|
Defining ranges for certainty ratings of diagnostic accuracy: a GRADE concept paper.
Journal of Clinical Epidemiology.
117:138-148.
2020
|
|
| 2020
|
Diagnostic accuracy of salivary gland ultrasound in Sjögren’s syndrome: A systematic review and meta-analysis.
Therapeutic Advances in Musculoskeletal Disease.
12.
2020
|
|
| 2020
|
Global injury morbidity and mortality from 1990 to 2017: Results from the global burden of disease study 2017.
Injury Prevention.
26:I96-I114.
2020
|
|
| 2020
|
Gout management and outcomes during the COVID-19 pandemic: a cross-sectional internet survey.
Therapeutic Advances in Musculoskeletal Disease.
12.
2020
|
|
| 2020
|
Juvenile idiopathic arthritis is associated with higher healthcare utilization after total knee or hip replacement.
Scandinavian Journal of Rheumatology.
34-39.
2020
|
|
| 2020
|
Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study.
Hypertension.
75:246-256.
2020
|
|
| 2020
|
Systemic sclerosis is associated with knee arthroplasty outcomes: a National US study.
Clinical Rheumatology.
39:85-92.
2020
|
|
| 2020
|
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017.
Lancet Gastroenterology and Hepatology.
5:17-30.
2020
|
|
| 2020
|
The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017.
Lancet Gastroenterology and Hepatology.
5:42-54.
2020
|
|
| 2019
|
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study.
JAMA Oncology.
5:1749-1768.
2019
|
|
| 2019
|
Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: A systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017.
Lancet HIV.
6:e831-e859.
2019
|
|
| 2019
|
Total knee arthroplasty outcomes in lupus: A study using the US National Inpatient Sample.
Rheumatology.
58:2130-2136.
2019
|
|
| 2019
|
Association of Early Postoperative Pain Trajectories with Longer-term Pain Outcome after Primary Total Knee Arthroplasty.
JAMA Network Open.
2.
2019
|
|
| 2019
|
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.
Annals of the Rheumatic Diseases.
78:1592-1600.
2019
|
|
| 2019
|
Association of Race/Ethnicity with Hospital Discharge Disposition after Elective Total Knee Arthroplasty.
JAMA Network Open.
2.
2019
|
|
| 2019
|
Mapping 123 million neonatal, infant and child deaths between 2000 and 2017.
Nature.
574:353-358.
2019
|
|
| 2019
|
Are the days of missed or delayed diagnosis of gout over?.
Nature Reviews Rheumatology.
15:578-580.
2019
|
|
| 2019
|
Factors influencing implementation of a computerized, individualized, culturally tailored lupus decision aid in lupus clinics: a qualitative semi-structured interview study.
Clinical Rheumatology.
38:2793-2801.
2019
|
|
| 2019
|
The risk of Sjogren's syndrome in the older adults with gout: A medicare claims study.
Joint Bone Spine.
86:615-619.
2019
|
|
| 2019
|
Tai chi for rheumatoid arthritis
2019
|
|
| 2019
|
Total joint replacement surgery for knee osteoarthritis and other non-traumatic diseases: a network meta-analysis
2019
|
|
| 2019
|
Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: A propensity-matched analysis of Medicare claims data.
European Heart Journal.
40:3046-3054.
2019
|
|
| 2019
|
Addressing challenges in developing a core domain set in adherence interventions in rheumatology: A report from the OMERACT-Adherence Group.
Journal of Rheumatology.
46:1202-1206.
2019
|
|
| 2019
|
Correction to: Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS) (Clinical Rheumatology, (2019), 38, 4, (1213-1216), 10.1007/s10067-019-04434-3).
Clinical Rheumatology.
38:2651-2653.
2019
|
|
| 2019
|
Identifying provisional generic contextual factor domains for clinical trials in rheumatology: Results from an OMERACT initiative.
Journal of Rheumatology.
46:1159-1163.
2019
|
|
| 2019
|
Rates of total joint replacement in the United States: Future projections to 2020-2040 using the national inpatient sample.
Journal of Rheumatology.
46:1134-1140.
2019
|
|
| 2019
|
The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017
2019
|
|
| 2019
|
Characterization of patients with chronic refractory gout who do and do not have clinically apparent tophi and their response to pegloticase.
Rheumatology.
58:1422-1431.
2019
|
|
| 2019
|
Core domain Set selection according to OMERACT filter 2.1: The OMERACT methodology.
Journal of Rheumatology.
46:1014-1020.
2019
|
|
| 2019
|
Gout is associated with increased healthcare utilization after knee arthroplasty.
Annals of the Rheumatic Diseases.
78:1146-1148.
2019
|
|
| 2019
|
Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT premeeting toward consensus on core sets for randomized controlled trials.
Journal of Rheumatology.
46:1053-1058.
2019
|
|
| 2019
|
Instrument selection using the OMERACT filter 2.1: The OMERACT methodology.
Journal of Rheumatology.
46:1028-1035.
2019
|
|
| 2019
|
OMERACT filter 2.1: Elaboration of the conceptual framework for outcome measurement in health intervention studies.
Journal of Rheumatology.
46:1021-1027.
2019
|
|
| 2019
|
The Third Biennial 2018 OMERACT First-time Participant Program: A qualitative and quantitative study.
Journal of Rheumatology.
46:1036-1040.
2019
|
|
| 2019
|
Filgotinib, a JAK1 Inhibitor, for Treatment-Resistant Rheumatoid Arthritis.
Journal of the American Medical Association.
322:309-311.
2019
|
|
| 2019
|
GRADE guidelines: 22. The GRADE approach for tests and strategies—from test accuracy to patient-important outcomes and recommendations.
Journal of Clinical Epidemiology.
111:69-82.
2019
|
|
| 2019
|
Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction?.
Drugs and Aging.
36:493-510.
2019
|
|
| 2019
|
Lupus is associated with poorer outcomes after primary total hip arthroplasty.
Lupus.
28:834-842.
2019
|
|
| 2019
|
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.
Lancet Neurology.
18:459-480.
2019
|
|
| 2019
|
Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial.
PLoS Medicine.
16.
2019
|
|
| 2019
|
Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS).
Clinical Rheumatology.
38:1213-1216.
2019
|
|
| 2019
|
Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.
Drugs.
79:531-541.
2019
|
|
| 2019
|
Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.
Lancet Neurology.
18:376-393.
2019
|
|
| 2019
|
Gout is associated with a higher risk of chronic renal disease in older adults: A retrospective cohort study of U.S. Medicare population.
BMC Nephrology.
20.
2019
|
|
| 2019
|
Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.
Arthritis Care and Research.
71:427-434.
2019
|
|
| 2019
|
Patient perspectives in gout: A review.
Current Opinion in Rheumatology.
31:159-166.
2019
|
|
| 2019
|
The association of gout with incident giant cell arteritis in older adults.
Joint Bone Spine.
86:219-224.
2019
|
|
| 2019
|
A Novel Method to Combine Assessment of Benefit and Harm: Outcome Measures in Rheumatology 3×3 Methodology Applied to Two Active Comparator Trials.
Arthritis Care and Research.
71:319-322.
2019
|
|
| 2019
|
Challenges of Practicing Rheumatology in a Government Setting: A County Hospital and Veterans Affairs Hospital Perspective.
Rheumatic Disease Clinics of North America.
45:39-51.
2019
|
|
| 2019
|
General Assembly, Prevention, Host Related General: Proceedings of International Consensus on Orthopedic Infections.
Journal of Arthroplasty.
34:S13-S35.
2019
|
|
| 2019
|
Tapering Janus kinase inhibitors in rheumatoid arthritis with low disease activity or remission: Reality or dream?.
Annals of the Rheumatic Diseases.
78:153-154.
2019
|
|
| 2019
|
Self-reported sleep quality and sleep disorders in people with physician-diagnosed gout: An Internet cross-sectional survey.
Arthritis Research and Therapy.
21.
2019
|
|
| 2019
|
Gout and the risk of Parkinson's disease in older adults: A study of U.S. Medicare data.
BMC Neurology.
19:V.
2019
|
|
| 2019
|
2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis
2019
|
|
| 2019
|
Burden of injury along the development spectrum: Associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017.
Injury Prevention.
2019
|
|
| 2019
|
Global, regional, and national burden of suicide mortality 1990 to 2016: Systematic analysis for the Global Burden of Disease Study 2016.
British medical journal.
364.
2019
|
|
| 2019
|
Gout and chronic pain in older adults: a Medicare claims study.
Clinical Rheumatology.
2019
|
|
| 2019
|
Gout and sexual function: Patient perspective of how gout affects personal relationships and intimacy.
BMC Rheumatology.
3.
2019
|
|
| 2019
|
Is there a role for cherries in the management of gout?.
Therapeutic Advances in Musculoskeletal Disease.
11.
2019
|
|
| 2019
|
OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions.
Journal of Rheumatology.
46:1409-1414.
2019
|
|
| 2019
|
Pain measurement in rheumatic and musculoskeletal diseases: Where to go from here? Report from a special interest group at OMERACT 2018.
Journal of Rheumatology.
46:355-1359.
2019
|
|
| 2019
|
Race, Discharge Disposition, and Readmissions after Elective Hip Replacement: Analysis of a Large Regional Dataset.
Health Equity.
3:628-636.
2019
|
|
| 2019
|
Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
Arthritis Care and Research.
71:2-29.
2019
|
|
| 2019
|
Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
Arthritis and Rheumatology.
71:5-32.
2019
|
|
| 2018
|
Effectiveness of healthcare educational and behavioral interventions to improve gout outcomes: a systematic review and meta-analysis.
Therapeutic Advances in Musculoskeletal Disease.
10:235-252.
2018
|
|
| 2018
|
Global, regional, and national burden of tuberculosis, 1990-2016: Results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study.
Lancet Infectious Diseases.
18:1329-1349.
2018
|
|
| 2018
|
Gout and the risk of incident depression in older adults.
Psychiatry Research.
270:842-844.
2018
|
|
| 2018
|
Erratum: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7))
2018
|
|
| 2018
|
Gout and dementia in the elderly: A cohort study of Medicare claims.
BMC Geriatrics.
18.
2018
|
|
| 2018
|
Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017
2018
|
|
| 2018
|
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
2018
|
|
| 2018
|
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017
2018
|
|
| 2018
|
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017
2018
|
|
| 2018
|
Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017
2018
|
|
| 2018
|
Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017
2018
|
|
| 2018
|
Any sleep is a dream far away: A nominal group study assessing how gout affects sleep.
Rheumatology.
57:1925-1932.
2018
|
|
| 2018
|
Correction to: Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines (Clinical Rheumatology, (2018), 37, 11, (2947-2959), 10.1007/s10067-018-4245-5).
Clinical Rheumatology.
37:2961-2962.
2018
|
|
| 2018
|
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.
Lancet Infectious Diseases.
18:1191-1210.
2018
|
|
| 2018
|
Is Rheumatoid Arthritis a Cardiovascular Risk-Equivalent to Diabetes Mellitus?.
Arthritis Care and Research.
70:1694-1699.
2018
|
|
| 2018
|
Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
2018
|
|
| 2018
|
Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines.
Clinical Rheumatology.
37:2947-2959.
2018
|
|
| 2018
|
Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patients.
Osteoarthritis and Cartilage.
26:1311-1318.
2018
|
|
| 2018
|
Response to: 'Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adults' by Lee and Song.
Annals of the Rheumatic Diseases.
77:e74.
2018
|
|
| 2018
|
Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis.
Seminars in Arthritis and Rheumatism.
48:293-301.
2018
|
|
| 2018
|
Gout and the risk of incident obstructive sleep apnea in adults 65 years or older: An observational study
2018
|
|
| 2018
|
Goals of gout treatment: a patient perspective.
Clinical Rheumatology.
37:2557-2566.
2018
|
|
| 2018
|
Medicaid or Medicare insurance payer status and household income are associated with outcomes after primary total hip arthroplasty.
Clinical Rheumatology.
37:2489-2496.
2018
|
|
| 2018
|
Global mortality from firearms, 1990-2016.
Journal of the American Medical Association.
320:792-814.
2018
|
|
| 2018
|
Opioids vs nonopioids for chronic back, hip, or knee pain.
Journal of the American Medical Association.
320:508.
2018
|
|
| 2018
|
Comparative effectiveness of allopurinol versus febuxostat for preventing incident dementia in older adults: A propensity-matched analysis.
Arthritis Research and Therapy.
20.
2018
|
|
| 2018
|
Gout and Hypothyroidism in the Elderly: an Observational Cohort Study Using U.S. Medicare Claims Data.
Journal of General Internal Medicine.
33:1229-1231.
2018
|
|
| 2018
|
Gout and hearing impairment in the elderly: A retrospective cohort study using the US Medicare claims data.
BMJ Open.
8.
2018
|
|
| 2018
|
Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adults.
Annals of the Rheumatic Diseases.
77:1243-1245.
2018
|
|
| 2018
|
Expert opinion on emerging urate-lowering therapies.
Expert Opinion on Emerging Drugs.
23:201-209.
2018
|
|
| 2018
|
Association of gout with uveitis in older individuals.
JAMA Ophthalmology.
136:835-837.
2018
|
|
| 2018
|
Gout and the risk of age-related macular degeneration in the elderly.
PLoS One.
13.
2018
|
|
| 2018
|
Response to: 'A response to singh. “Lesinurad combination therapy with allopurinol in gout: Do CLEAR studies make the treatment of gout clearer?”' by valiyil and schechter.
Annals of the Rheumatic Diseases.
77.
2018
|
|
| 2018
|
The risk of polymyalgia rheumatica in older adults with gout: A Medicare claims study.
Rheumatology Advances in Practice.
2:1-7.
2018
|
|
| 2018
|
Interleukin inhibitors for psoriatic arthritis
2018
|
|
| 2018
|
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016
2018
|
|
| 2018
|
Gout and the risk of myocardial infarction in older adults: A study of Medicare recipients.
Arthritis Research and Therapy.
20.
2018
|
|
| 2018
|
Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities.
Arthritis Research and Therapy.
20.
2018
|
|
| 2018
|
Adolescent health in the Eastern Mediterranean Region: findings from the global burden of disease 2015 study.
Gesundheit und Wohlfahrt. Revue suisse d'hygiene.
63:79-96.
2018
|
|
| 2018
|
Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990–2015: findings from the Global Burden of Disease 2015 study.
Gesundheit und Wohlfahrt. Revue suisse d'hygiene.
63:137-149.
2018
|
|
| 2018
|
Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and 2015: findings from the Global Burden of Disease 2015 study.
Gesundheit und Wohlfahrt. Revue suisse d'hygiene.
63:97-108.
2018
|
|
| 2018
|
Burden of obesity in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study.
Gesundheit und Wohlfahrt. Revue suisse d'hygiene.
63:165-176.
2018
|
|
| 2018
|
Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout.
Arthritis Care and Research.
70:659-671.
2018
|
|
| 2018
|
Maternal mortality and morbidity burden in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study.
Gesundheit und Wohlfahrt. Revue suisse d'hygiene.
63:47-61.
2018
|
|
| 2018
|
Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
British Journal of Dermatology.
178:e332-e341.
2018
|
|
| 2018
|
The burden of mental disorders in the Eastern Mediterranean region, 1990–2015: findings from the global burden of disease 2015 study.
Gesundheit und Wohlfahrt. Revue suisse d'hygiene.
63:25-37.
2018
|
|
| 2018
|
Trends in HIV/AIDS morbidity and mortality in Eastern Mediterranean countries, 1990–2015: findings from the Global Burden of Disease 2015 study.
Gesundheit und Wohlfahrt. Revue suisse d'hygiene.
63:123-136.
2018
|
|
| 2018
|
The state of US health, 1990-2016: Burden of diseases, injuries, and risk factors among US states.
Journal of the American Medical Association.
319:1444-1472.
2018
|
|
| 2018
|
Developing a core outcome domain set to assessing effectiveness of interdisciplinary multimodal pain therapy: The VAPAIN consensus statement on core outcome domains.
Pain.
159:673-683.
2018
|
|
| 2018
|
EULAR gout treatment guidelines by Richette et al.: Uric acid and neurocognition.
Annals of the Rheumatic Diseases.
77.
2018
|
|
| 2018
|
Epilepsy and psychosis: A practical approach.
Practical Neurology.
18:106-114.
2018
|
|
| 2018
|
Medication adherence among patients with gout: A systematic review and meta-analysis.
Seminars in Arthritis and Rheumatism.
47:689-702.
2018
|
|
| 2018
|
Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
Trials.
19.
2018
|
|
| 2018
|
Allopurinol and the risk of incident peripheral arterial disease in the elderly: A us medicare claims data study.
Rheumatology.
57:451-461.
2018
|
|
| 2018
|
Brief Report: Validation of a Definition of Flare in Patients With Established Gout.
Arthritis and Rheumatology.
70:462-467.
2018
|
|
| 2018
|
Role of serum urate in neurocognitive function and dementia: New evidence contradicts old thinking.
Annals of the Rheumatic Diseases.
77:317-318.
2018
|
|
| 2018
|
The global burden of tuberculosis: results from the Global Burden of Disease Study 2015.
Lancet Infectious Diseases.
18:261-284.
2018
|
|
| 2018
|
Trends in opioid and nonsteroidal anti-inflammatory use and adverse events.
American Journal of Managed Care.
24:e61-e72.
2018
|
|
| 2018
|
Variability in the reporting of serum urate and flares in gout clinical trials: Need for minimum reporting requirements.
Journal of Rheumatology.
45:419-424.
2018
|
|
| 2018
|
Correction: Patients and surgeons provide endorsement of core domains for total joint replacement clinical trials. [Arthritis Res Ther. 19, (2017)(267)] DOI: 10.1186/s13075-017-1476-9.
Arthritis Research and Therapy.
20.
2018
|
|
| 2018
|
Septic Arthritis in Emergency Departments in the US: A National Study of Health Care Utilization and Time Trends.
Arthritis Care and Research.
70:320-326.
2018
|
|
| 2018
|
Taking an Interdisciplinary Approach to Understanding and Improving Medication Adherence.
Journal of General Internal Medicine.
33:136-138.
2018
|
|
| 2018
|
Trends in joint replacement surgery in patients with rheumatoid arthritis.
Journal of Rheumatology.
45:158-164.
2018
|
|
| 2018
|
Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance)..
International Journal of Statistics in Medical Research.
7:137-146.
2018
|
|
| 2018
|
Gout and the risk of incident atrial fibrillation in older adults: a study of US Medicare data..
RMD Open.
4:e000712.
2018
|
|
| 2017
|
Patients and surgeons provide endorsement of core domains for total joint replacement clinical trials.
Arthritis Research and Therapy.
19.
2017
|
|
| 2017
|
2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups.
Arthritis and Rheumatology.
69:2271-2282.
2017
|
|
| 2017
|
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.
Annals of the Rheumatic Diseases.
76:1955-1964.
2017
|
|
| 2017
|
Considering health equity when moving from evidence-based guideline recommendations to implementation: A case study from an upper-middle income country on the GRADE approach.
Health Policy and Planning.
32:1484-1490.
2017
|
|
| 2017
|
Validating rheumatoid arthritis remission using the patients' perspective: Results from a special interest group at OMERACT 2016.
Journal of Rheumatology.
44:1889-1893.
2017
|
|
| 2017
|
Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy
2017
|
|
| 2017
|
Weight loss for overweight patients with knee or hip osteoarthritis
2017
|
|
| 2017
|
Achieving consensus on total joint replacement trial outcome reporting using the OMERACT filter: Endorsement of the final core domain set for total hip and total knee replacement trials for endstage arthritis.
Journal of Rheumatology.
44:1723-1726.
2017
|
|
| 2017
|
Gout Self-Management in African American Veterans: A Qualitative Exploration of Challenges and Solutions From Patients' Perspectives.
Arthritis Care and Research.
69:1724-1732.
2017
|
|
| 2017
|
Health equity considerations for developing and reporting patient-reported outcomes in clinical trials: A report from the omeract equity special interest group.
Journal of Rheumatology.
44:1727-1733.
2017
|
|
| 2017
|
Patient-Reported Outcomes Can Be Used to Streamline Post-Total Hip Arthroplasty Follow-Up to High-Risk Patients.
Journal of Arthroplasty.
32:3319-3321.
2017
|
|
| 2017
|
Weight loss for overweight and obese individuals with gout: A systematic review of longitudinal studies.
Annals of the Rheumatic Diseases.
76:1870-1882.
2017
|
|
| 2017
|
Erratum: Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 (The Lancet (2017) 390(10100) (1423–1459) (S014067361732336X) (10.1016/S0140-6736(17)32336-X))
2017
|
|
| 2017
|
Erratum: Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: An exemplar of the GRADE Adolopment [Health Qual Life Outcomes., 15, (2017)(183)] DOI: 10.1186/s12955-017-0754-1.
Health and Quality of Life Outcomes.
15.
2017
|
|
| 2017
|
Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study.
Arthritis Research and Therapy.
19.
2017
|
|
| 2017
|
Comparative effectiveness of allopurinol versus febuxostat for preventing incident renal disease in older adults: An analysis of Medicare claims data.
Annals of the Rheumatic Diseases.
76:1669-1678.
2017
|
|
| 2017
|
Engaging stakeholders and promoting uptake of OMERACT core outcome instrument sets.
Journal of Rheumatology.
44:1551-1559.
2017
|
|
| 2017
|
GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationale.
Journal of Clinical Epidemiology.
90:59-67.
2017
|
|
| 2017
|
GRADE equity guidelines 2: considering health equity in GRADE guideline development: equity extension of the guideline development checklist.
Journal of Clinical Epidemiology.
90:68-75.
2017
|
|
| 2017
|
GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence.
Journal of Clinical Epidemiology.
90:76-83.
2017
|
|
| 2017
|
GRADE equity guidelines 4: considering health equity in GRADE guideline development: evidence to decision process.
Journal of Clinical Epidemiology.
90:84-91.
2017
|
|
| 2017
|
Patient Burden of Axial Spondyloarthritis
2017
|
|
| 2017
|
Patient Burden of Axial Spondyloarthritis.
2017
|
|
| 2017
|
The OMERACT first-time participant program: Fresh eye from the new guys.
Journal of Rheumatology.
44:1560-1563.
2017
|
|
| 2017
|
Erratum:Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 (The Lancet (2017) 390(10100) (1423–1459) (S014067361732336X)(10.1016/S0140-6736(17)32336-X))
2017
|
|
| 2017
|
Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: An exemplar of the GRADE Adolopment.
Health and Quality of Life Outcomes.
15.
2017
|
|
| 2017
|
Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016
2017
|
|
| 2017
|
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016
2017
|
|
| 2017
|
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016
2017
|
|
| 2017
|
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016
2017
|
|
| 2017
|
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016
2017
|
|
| 2017
|
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: An analysis from the Global Burden of Disease Study 2016
2017
|
|
| 2017
|
Gout and comorbidity: A nominal group study of people with gout.
Arthritis Research and Therapy.
19.
2017
|
|
| 2017
|
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Journal of Arthroplasty.
32:2628-2638.
2017
|
|
| 2017
|
Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans.
Arthritis Care and Research.
69:1400-1406.
2017
|
|
| 2017
|
Biologic drugs for induction and maintenance of remission in Crohn's disease: A network meta-analysis
2017
|
|
| 2017
|
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Arthritis and Rheumatology.
69:1538-1551.
2017
|
|
| 2017
|
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Arthritis Care and Research.
69:1111-1124.
2017
|
|
| 2017
|
Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: Findings from the Global Burden of Disease Study 2013.
Annals of the Rheumatic Diseases.
76:1365-1373.
2017
|
|
| 2017
|
Clinical Practice Guidelines: Incorporating Input From a Patient Panel.
Arthritis Care and Research.
69:1125-1130.
2017
|
|
| 2017
|
Outcome measures used in arthroplasty trials: Systematic review of the 2008 and 2013 literature.
Journal of Rheumatology.
44:1277-1287.
2017
|
|
| 2017
|
The burden of septic arthritis on the U.S. inpatient care: A national study.
PLoS One.
12.
2017
|
|
| 2017
|
Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015
2017
|
|
| 2017
|
Health effects of overweight and obesity in 195 countries over 25 years.
New England Journal of Medicine.
377:13-27.
2017
|
|
| 2017
|
Management of gout.
ACP journal club.
166:855.
2017
|
|
| 2017
|
Child and adolescent health from 1990 to 2015: Findings from the global burden of diseases, injuries, and risk factors 2015 study.
JAMA Pediatrics.
171:573-592.
2017
|
|
| 2017
|
Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials.
Seminars in Arthritis and Rheumatism.
46:699-708.
2017
|
|
| 2017
|
Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial.
Clinical Rheumatology.
36:1357-1367.
2017
|
|
| 2017
|
Receipt of Pain Management Information Preoperatively Is Associated With Improved Functional Gain After Elective Total Joint Arthroplasty.
Journal of Arthroplasty.
32:1763-1768.
2017
|
|
| 2017
|
Health care utilization in patients with gout: a prospective multicenter cohort study.
BMC Musculoskeletal Disorders.
18.
2017
|
|
| 2017
|
Do outcomes reported in randomised controlled trials of joint replacement surgery fulfil the OMERACT 2.0 Filter? A review of the 2008 and 2013 literature.
Systematic Reviews.
6.
2017
|
|
| 2017
|
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: A systematic analysis from the global burden of disease study 2015
2017
|
|
| 2017
|
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: A systematic review and network meta-analysis.
Cochrane Database of Systematic Reviews.
2017.
2017
|
|
| 2017
|
Lesinurad combination therapy with allopurinol in gout: Do CLEAR studies make the treatment of gout clearer?.
Annals of the Rheumatic Diseases.
76:779-781.
2017
|
|
| 2017
|
Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis c virus infection.
Journal of Rheumatology.
44:565-570.
2017
|
|
| 2017
|
Chasing crystals out of the body: Will treat to serum urate target for gout help us get there?.
Annals of the Rheumatic Diseases.
76:629-631.
2017
|
|
| 2017
|
Evaluation and Management of the Patient With Suspected Inflammatory Spine Disease.
Mayo Clinic Proceedings.
92:555-564.
2017
|
|
| 2017
|
Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.
British Journal of Dermatology.
176:979-984.
2017
|
|
| 2017
|
Successful Stepwise Development of Patient Research Partnership: 14 Years’ Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT)
2017
|
|
| 2017
|
Allopurinol and the risk of ventricular arrhythmias in the elderly: A study using US Medicare data.
BMC Medicine.
15.
2017
|
|
| 2017
|
Patient Endorsement of the Outcome Measures in Rheumatology (OMERACT) Total Joint Replacement (TJR) clinical trial draft core domain set.
BMC Musculoskeletal Disorders.
18.
2017
|
|
| 2017
|
Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.
BMC Cardiovascular Disorders.
17.
2017
|
|
| 2017
|
Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: A systematic review and network meta-analysis.
Cochrane Database of Systematic Reviews.
2017.
2017
|
|
| 2017
|
Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized, controlled trial.
BMC Musculoskeletal Disorders.
18:1-10.
2017
|
|
| 2017
|
Consensus on draft OMERACT core domains for clinical trials of Total Joint Replacement outcome by orthopaedic surgeons: A report from the International consensus on outcome measures in TJR trials (I-COMiTT) group.
BMC Musculoskeletal Disorders.
18.
2017
|
|
| 2017
|
Cytokine and neuropeptide levels are associated with pain relief in patients with chronically painful total knee arthroplasty: A pilot study.
BMC Musculoskeletal Disorders.
18.
2017
|
|
| 2017
|
An underlying diagnosis of osteonecrosis of bone is associated with worse outcomes than osteoarthritis after total hip arthroplasty.
BMC Musculoskeletal Disorders.
18.
2017
|
|
| 2017
|
Erratum: Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1775–1812)(S0140673616314702)(10.1016/S0140-6736(16)31470-2))
2017
|
|
| 2017
|
Erratum: Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1725–1774)(S0140673616315756)(10.1016/S0140-6736(16)31575-6))
2017
|
|
| 2017
|
Allopurinol and the risk of atrial fibrillation in the elderly: A study using medicare data.
Annals of the Rheumatic Diseases.
76:72-78.
2017
|
|
| 2017
|
Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failure.
Annals of the Rheumatic Diseases.
76:133-139.
2017
|
|
| 2017
|
EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: A methodology report.
RMD Open.
3.
2017
|
|
| 2017
|
Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.
Obstetrical and Gynecological Survey.
72:11-13.
2017
|
|
| 2017
|
Prognostic significance of baseline fatigue for overall survival: A patient-level meta-analysis of 43 oncology clinical trials with 3915 patients..
Trends in cancer research.
12:97-110.
2017
|
|
| 2017
|
Racial differences in health-related quality of life and functional ability in patients with gout.
Rheumatology.
56:103-112.
2017
|
|
| 2017
|
Renal dosing of allopurinol results in suboptimal gout care.
Annals of the Rheumatic Diseases.
76.
2017
|
|
| 2017
|
The Association of Vibratory Perception and Muscle Strength With the Incidence and Worsening of Knee Instability: The Multicenter Osteoarthritis Study.
Arthritis and Rheumatology.
69:94-102.
2017
|
|
| 2017
|
The Burden of the Fellowship Interview Process on General Surgery Residents and Programs.
Journal of Surgical Education.
74:167-172.
2017
|
|
| 2016
|
Mapping Perceptions of Lupus Medication Decision-Making Facilitators: The Importance of Patient Context.
Arthritis Care and Research.
68:1787-1794.
2016
|
|
| 2016
|
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: A Cochrane Systematic Review and network meta-analysis (NMA).
Cochrane Database of Systematic Reviews.
2016.
2016
|
|
| 2016
|
Gout: Will the "King of Diseases" Be the first rheumatic disease to be cured.
BMC Medicine.
14.
2016
|
|
| 2016
|
Development of the American College of Rheumatology’s Rheumatoid Arthritis Electronic Clinical Quality Measures.
Arthritis Care and Research.
68:1579-1590.
2016
|
|
| 2016
|
Nonunion of first rib fracture in a softball player: case report of a rare cause of thoracic outlet syndrome.
Journal of Shoulder and Elbow Surgery.
25:e353-e357.
2016
|
|
| 2016
|
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
2016
|
|
| 2016
|
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
2016
|
|
| 2016
|
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
2016
|
|
| 2016
|
Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
2016
|
|
| 2016
|
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
2016
|
|
| 2016
|
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
2016
|
|
| 2016
|
Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
2016
|
|
| 2016
|
Increasing comorbidity is associated with worsening physical function and pain after primary total knee arthroplasty.
BMC Musculoskeletal Disorders.
17:1-10.
2016
|
|
| 2016
|
Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis.
Annals of the Rheumatic Diseases.
75:1813-1818.
2016
|
|
| 2016
|
Does T'ai Chi Gait Reduce External Knee Adduction Moment?.
Journal of Alternative and Complementary Medicine.
22:818-823.
2016
|
|
| 2016
|
Infections With Biologics in Rheumatoid Arthritis and Related Conditions: a Scoping Review of Serious or Hospitalized Infections in Observational Studies.
Current Rheumatology Reports.
18.
2016
|
|
| 2016
|
Sex-related Outcome Inequalities in Endovascular Aneurysm Repair.
European Journal of Vascular and Endovascular Surgery.
52:518-525.
2016
|
|
| 2016
|
Treatments for lupus nephritis: A systematic review and network metaanalysis.
Journal of Rheumatology.
43:1801-1815.
2016
|
|
| 2016
|
Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: A study of Medicare claims.
Arthritis Research and Therapy.
18.
2016
|
|
| 2016
|
Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: A systematic review and network meta-analysis.
Systematic Reviews.
5.
2016
|
|
| 2016
|
Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: A systematic review and network meta-analysis.
BMC Medicine.
14.
2016
|
|
| 2016
|
Allopurinol and the risk of stroke in older adults receiving medicare.
BMC Neurology.
16.
2016
|
|
| 2016
|
Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations.
Pain.
157:1836-1850.
2016
|
|
| 2016
|
Erratum: Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: The Global Burden of Disease Study 2015 (The Lancet HIV (2016) 3 (e361-e387) PII: S235230181630087X DOI: 10.1016/S2352-3018(16)30087-X).
Lancet HIV.
3:e408.
2016
|
|
| 2016
|
Metabolic syndrome and shoulder arthroplasty: epidemiology and peri-operative outcomes.
International Orthopaedics.
40:1927-1933.
2016
|
|
| 2016
|
Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination.
Arthritis and Rheumatology.
68:2328-2337.
2016
|
|
| 2016
|
How often is the office visit needed? Predicting total knee arthroplasty revision risk using pain/function scores.
BMC Health Services Research.
16.
2016
|
|
| 2016
|
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015.
Lancet HIV.
3:e361-e387.
2016
|
|
| 2016
|
GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health.
Journal of Clinical Epidemiology.
76:89-98.
2016
|
|
| 2016
|
Time trends, predictors, and outcome of emergency department use for gout: A nationwide US study.
Journal of Rheumatology.
43:1581-1588.
2016
|
|
| 2016
|
Emergency Department and Inpatient Healthcare utilization due to Hypertension.
BMC Health Services Research.
16.
2016
|
|
| 2016
|
Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
International Journal of Pharmaceutics.
509:465-476.
2016
|
|
| 2016
|
Cervical cancer risk with the use of tumour necrosis factor inhibitors in rheumatoid arthritis: To worry or not to worry?.
Annals of the Rheumatic Diseases.
75:1265-1267.
2016
|
|
| 2016
|
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
British Journal of Dermatology.
175:69-79.
2016
|
|
| 2016
|
Clinically important improvement thresholds for Harris Hip Score and its ability to predict revision risk after primary total hip arthroplasty.
BMC Musculoskeletal Disorders.
17.
2016
|
|
| 2016
|
Performance of Gout Impact Scale in a longitudinal observational study of patients with gout.
Rheumatology.
55:982-990.
2016
|
|
| 2016
|
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: A systematic review and network meta-analysis.
Cochrane Database of Systematic Reviews.
2016.
2016
|
|
| 2016
|
Do pessimists report worse outcomes after total hip arthroplasty?.
BMC Musculoskeletal Disorders.
17.
2016
|
|
| 2016
|
Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.
Arthritis Care and Research.
68:667-672.
2016
|
|
| 2016
|
Reply.
Arthritis and Rheumatology.
68:1316-1318.
2016
|
|
| 2016
|
Reply.
Arthritis Care and Research.
68:725-726.
2016
|
|
| 2016
|
Regional analgesia versus no regional analgesia for ambulatory hip arthroscopy in adults
2016
|
|
| 2016
|
Ms. A.M. Taylor, et al reply.
Journal of Rheumatology.
43:826.
2016
|
|
| 2016
|
Racial/Ethnic Disparity in Rates and Outcomes of Total Joint Arthroplasty.
Current Rheumatology Reports.
18.
2016
|
|
| 2016
|
The Global Burden of Anemia
2016
|
|
| 2016
|
Gout-related inpatient utilization: A study of predictors of outcomes and time trends.
Arthritis Research and Therapy.
18.
2016
|
|
| 2016
|
A cross-sectional internet-based patient survey of the management strategies for gout.
BMC Complementary and Alternative Medicine.
16.
2016
|
|
| 2016
|
Sex differences in characteristics, utilization, and outcomes of patient undergoing total elbow arthroplasty: a study of the US nationwide inpatient sample.
Clinical Rheumatology.
35:723-731.
2016
|
|
| 2016
|
Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: Data from the National Veterans Health Administration.
Annals of the Rheumatic Diseases.
75:341-347.
2016
|
|
| 2016
|
Does rural residence impact total ankle arthroplasty utilization and outcomes?.
Clinical Rheumatology.
35:381-386.
2016
|
|
| 2016
|
Serum urate gene associations with incident gout, measured in the Framingham Heart Study, are modified by renal disease and not by body mass index
2016
|
|
| 2016
|
Validation of the Mayo Hip Score: Construct validity, reliability and responsiveness to change Orthopedics and biomechanics.
BMC Musculoskeletal Disorders.
17.
2016
|
|
| 2016
|
Utilization due to chronic obstructive pulmonary disease and its predictors: A study using the U.S. National Emergency Department Sample (NEDS).
Respiratory Research.
17.
2016
|
|
| 2016
|
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Arthritis and Rheumatology.
68:1-26.
2016
|
|
| 2016
|
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Arthritis Care and Research.
68:1-26.
2016
|
|
| 2016
|
Depression and anxiety following coronary artery bypass graft: Current indian scenario.
Cardiology Research and Practice.
2016.
2016
|
|
| 2016
|
GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines.
British medical journal.
353.
2016
|
|
| 2016
|
Time trends in total ankle arthroplasty in the USA: a study of the National Inpatient Sample.
Clinical Rheumatology.
35:239-245.
2016
|
|
| 2016
|
Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis.
BMJ Open.
6.
2016
|
|
| 2016
|
When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis.
Arthritis Care and Research.
68:26-35.
2016
|
|
| 2015
|
Minorities with lupus nephritis and medications: A study of facilitators to medication decision-making.
Arthritis Research and Therapy.
17.
2015
|
|
| 2015
|
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
2015
|
|
| 2015
|
Imaging as an outcome measure in gout studies: Report from the OMERACT gout working group.
Journal of Rheumatology.
42:2460-2464.
2015
|
|
| 2015
|
Outcome domains and measures in total joint replacement clinical trials: Can we harmonize them? An OMERACT collaborative initiative.
Journal of Rheumatology.
42:2496-2502.
2015
|
|
| 2015
|
Toward ensuring health equity: Readability and cultural equivalence of OMERACT patient-reported outcome measures.
Journal of Rheumatology.
42:2448-2459.
2015
|
|
| 2015
|
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition
2015
|
|
| 2015
|
Current tobacco use is associated with higher rates of implant revision and deep infection after total hip or knee arthroplasty: A prospective cohort study.
BMC Medicine.
13.
2015
|
|
| 2015
|
Are There Modifiable Risk Factors for Hospital Readmission After Total Hip Arthroplasty in a US Healthcare System?.
Clinical Orthopaedics and Related Research.
473:3446-3455.
2015
|
|
| 2015
|
2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative.
Arthritis and Rheumatology.
67:2557-2568.
2015
|
|
| 2015
|
2015 Gout classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Annals of the Rheumatic Diseases.
74:1789-1798.
2015
|
|
| 2015
|
A call for evidence-based decision making when selecting outcome measurement instruments for summary of findings tables in systematic reviews: Results from an OMERACT working group.
Journal of Rheumatology.
42:1954-1961.
2015
|
|
| 2015
|
Age-related differences in the use of total shoulder arthroplasty over time: USE and OUTCOMES.
Bone and Joint Journal.
97-B:1385-1389.
2015
|
|
| 2015
|
Consensus on the need for a hierarchical list of patient-reported pain outcomes for metaanalyses of knee osteoarthritis trials: An OMERACT objective.
Journal of Rheumatology.
42:1971-1975.
2015
|
|
| 2015
|
Current state of reporting pain outcomes in cochrane reviews of chronic musculoskeletal pain conditions and considerations for an OMERACT research agenda.
Journal of Rheumatology.
42:1934-1942.
2015
|
|
| 2015
|
Do "evidence-based recommendations" need to reveal the evidence? Minimal criteria supporting an "evidence claim".
Journal of Rheumatology.
42:1737-1739.
2015
|
|
| 2015
|
Harmonizing pain outcome measures: Results of the pre-OMERACT meeting on partnerships for consensus on patient-important pain outcome domains between the cochrane musculoskeletal group and OMERACT.
Journal of Rheumatology.
42:1943-1946.
2015
|
|
| 2015
|
Is chronic pain a disease in its own right? Discussions from a pre-OMERACT 2014 workshop on chronic pain.
Journal of Rheumatology.
42:1947-1953.
2015
|
|
| 2015
|
Optimal strategies for reporting pain in clinical trials and systematic reviews: Recommendations from an OMERACT 12 workshop.
Journal of Rheumatology.
42:1962-1970.
2015
|
|
| 2015
|
The OMERACT first-time participant ("Newbie") program: Initial assessment and lessons learned.
Journal of Rheumatology.
42:1976-1981.
2015
|
|
| 2015
|
Are there racial disparities in utilization and outcomes after total elbow arthroplasty?
2015
|
|
| 2015
|
Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: Analyses from large U.S. managed care cohort [Arthritis Res Ther. 2015;17:120].
Arthritis Research and Therapy.
17.
2015
|
|
| 2015
|
Barriers to medication decision making in women with lupus nephritis: A formative study using nominal group technique.
Journal of Rheumatology.
42:1616-1623.
2015
|
|
| 2015
|
Validity and sensitivity to change of three scales for the radiographic assessment of knee osteoarthritis using images from the Multicenter Osteoarthritis Study (MOST).
Osteoarthritis and Cartilage.
23:1491-1498.
2015
|
|
| 2015
|
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
2015
|
|
| 2015
|
Persisting racial disparities in total shoulder arthroplasty utilization and outcomes.
Journal of Racial and Ethnic Health Disparities.
3:259-266.
2015
|
|
| 2015
|
Adherence to the 2012 American college of rheumatology (ACR) guidelines for management of gout: A survey of Brazilian rheumatologists.
PLoS One.
10.
2015
|
|
| 2015
|
Investigational drugs for hyperuricemia.
Expert Opinion on Investigational Drugs.
24:1013-1030.
2015
|
|
| 2015
|
Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance).
Osteoporosis International.
26:1971-1977.
2015
|
|
| 2015
|
Risk of serious infection in biological treatment of patients with rheumatoid arthritis: A systematic review and meta-analysis
2015
|
|
| 2015
|
The Global Burden of Cancer 2013.
JAMA Oncology.
1:505-527.
2015
|
|
| 2015
|
Total joint replacement surgery for knee osteoarthritis and other non-traumatic diseases: A network meta-analysis
2015
|
|
| 2015
|
An Internet survey of common treatments used by patients with gout including cherry extract and juice and other dietary supplements
2015
|
|
| 2015
|
Subcutaneous or intramuscular methotrexate for rheumatoid arthritis
2015
|
|
| 2015
|
Validation of administrative codes for calcium pyrophosphate deposition: A veterans administration study
2015
|
|
| 2015
|
Does hospital volume predict outcomes and complications after total shoulder arthroplasty in the US?.
Arthritis Care and Research.
67:885-890.
2015
|
|
| 2015
|
Outcomes of augmented allograft figure-of-eight sternoclavicular joint reconstruction.
Journal of Shoulder and Elbow Surgery.
24:902-907.
2015
|
|
| 2015
|
The Effect of Arthroscopic Rotator Interval Closure on Glenohumeral Volume.
American journal of orthopedics (Belle Mead, N.J.).
44:E190-E194.
2015
|
|
| 2015
|
Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection: A retrospective cohort study.
Arthritis Research and Therapy.
17.
2015
|
|
| 2015
|
Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: Analyses from large U.S. managed care cohort.
Arthritis Research and Therapy.
17.
2015
|
|
| 2015
|
Rheumatoid arthritis is associated with higher ninety-day hospital readmission rates compared to osteoarthritis after hip or knee arthroplasty: A cohort study.
Arthritis Care and Research.
67:718-724.
2015
|
|
| 2015
|
TNF-alpha inhibitors for ankylosing spondylitis.
Cochrane Database of Systematic Reviews.
2015.
2015
|
|
| 2015
|
When gout goes to the heart: Does gout equal a cardiovascular disease risk factor?.
Annals of the Rheumatic Diseases.
74:631-634.
2015
|
|
| 2015
|
Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adults
2015
|
|
| 2015
|
Racial disparities in total ankle arthroplasty utilization and outcomes.
Arthritis Research and Therapy.
17.
2015
|
|
| 2015
|
Regional analgesia versus no regional analgesia for ambulatory hip arthroscopy in adults
2015
|
|
| 2015
|
Comparative analysis of anatomic and reverse total shoulder arthroplasty: In-hospital outcomes and costs.
Journal of Shoulder and Elbow Surgery.
24:460-467.
2015
|
|
| 2015
|
Is the double contour sign specific for gout? Or only for crystal arthritis?.
Journal of Rheumatology.
42:353-354.
2015
|
|
| 2015
|
Exercise therapy following surgical rotator cuff repair
2015
|
|
| 2015
|
Chondroitin for osteoarthritis
2015
|
|
| 2015
|
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
2015
|
|
| 2015
|
A real-world study of switching from allopurinol to febuxostat in a health plan database
2015
|
|
| 2015
|
Assessing the reading level of online sarcoma patient education materials.
American journal of orthopedics (Belle Mead, N.J.).
44:E1-E10.
2015
|
|
| 2015
|
Muscle inflammation susceptibility: A prognostic index of recovery potential after hip arthroplasty?
2015
|
|
| 2015
|
Patient-centered priorities for improving medication management and adherence.
Patient Education and Counseling.
98:102-110.
2015
|
|
| 2015
|
Persisting Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes..
Journal of Racial and Ethnic Health Disparities.
2015:1-8.
2015
|
|
| 2014
|
Improving the readability of online foot and ankle patient education materials.
Foot and Ankle International.
35:1282-1286.
2014
|
|
| 2014
|
Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales.
Health and Quality of Life Outcomes.
12.
2014
|
|
| 2014
|
Antidepressants for people with epilepsy and depression
2014
|
|
| 2014
|
Patient-centered interventions to improve medication management and adherence: A qualitative review of research findings.
Patient Education and Counseling.
97:310-326.
2014
|
|
| 2014
|
Racial disparities in knee and hip total joint arthroplasty: An 18-year analysis of national medicare data.
Annals of the Rheumatic Diseases.
73:2107-2115.
2014
|
|
| 2014
|
Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME).
British Journal of Dermatology.
171:1318-1325.
2014
|
|
| 2014
|
Impaired response or insufficient dosage?-Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout.
Seminars in Arthritis and Rheumatism.
44:170-174.
2014
|
|
| 2014
|
Predictors of pain medication use for arthroplasty pain after revision total knee arthroplasty.
Rheumatology.
53:1752-1758.
2014
|
|
| 2014
|
The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials.
Journal of Allergy and Clinical Immunology.
134:800-807.
2014
|
|
| 2014
|
A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis.
British medical journal.
349.
2014
|
|
| 2014
|
Global, regional, and national levels and causes of maternal mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
2014
|
|
| 2014
|
The impact of gout on patient's lives: A study of African-American and Caucasian men and women with gout.
Arthritis Research and Therapy.
16.
2014
|
|
| 2014
|
Antipsychotics for people with epilepsy and psychosis
2014
|
|
| 2014
|
Depression in primary TKA and higher medical comorbidities in revision TKA are associated with suboptimal subjective improvement in knee function.
BMC Musculoskeletal Disorders.
15.
2014
|
|
| 2014
|
Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: A qualitative study.
Arthritis Research and Therapy.
16.
2014
|
|
| 2014
|
Patient-level improvements in pain and activities of daily living after total knee arthroplasty.
Rheumatology.
53:313-320.
2014
|
|
| 2014
|
Underlying diagnosis predicts patient-reported outcomes after revision total knee arthroplasty.
Rheumatology.
53:361-366.
2014
|
|
| 2014
|
Update of strategies to translate evidence from cochrane musculoskeletal group systematic reviews for use by various audiences.
Journal of Rheumatology.
41:206-215.
2014
|
|
| 2014
|
Updated method guidelines for cochrane musculoskeletal group systematic reviews and metaanalyses.
Journal of Rheumatology.
41:194-205.
2014
|
|
| 2014
|
Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute gout.
Journal of Rheumatology.
41:574-580.
2014
|
|
| 2014
|
Are outcomes after total knee arthroplasty worsening over time? A time-trends study of activity limitation and pain outcomes.
BMC Musculoskeletal Disorders.
15.
2014
|
|
| 2014
|
Arthroplasty outcomes are improving, but why isn't my patient with rheumatoid arthritis doing as well?.
Arthritis and Rheumatology.
66:250-253.
2014
|
|
| 2014
|
Bariatric surgery prior to total joint arthroplasty may not provide dramatic improvements in post-arthroplasty surgical outcomes.
Journal of Arthroplasty.
29:1359-1364.
2014
|
|
| 2014
|
Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: An update.
Quality of Life Research.
23:1997-2013.
2014
|
|
| 2014
|
Cerebrovascular disease is associated with outcomes after total knee arthroplasty: A us total joint registry study.
Journal of Arthroplasty.
29:40-43.
2014
|
|
| 2014
|
Challenges faced by patients in gout treatment: A qualitative study
2014
|
|
| 2014
|
Comorbidities in patients with crystal diseases and hyperuricemia.
Rheumatic Disease Clinics of North America.
40:251-278.
2014
|
|
| 2014
|
Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.
Journal of Clinical Epidemiology.
67:745-753.
2014
|
|
| 2014
|
Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplasty.
Journal of Shoulder and Elbow Surgery.
23:671-678.
2014
|
|
| 2014
|
Does clinically important change in function after knee replacement guarantee good absolute function? the multicenter osteoarthritis study.
Journal of Rheumatology.
41:60-64.
2014
|
|
| 2014
|
Efficacy of Long-term Effect and Repeat Intraarticular Botulinum toxin in Patients with Painful Total Joint Arthroplasty: A Retrospective Study..
British Journal of Medicine and Medical Research.
4:139-148.
2014
|
|
| 2014
|
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
2014
|
|
| 2014
|
Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
2014
|
|
| 2014
|
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013
2014
|
|
| 2014
|
How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
Journal of Rheumatology.
41:1025-1030.
2014
|
|
| 2014
|
Including health equity considerations in development of instruments for rheumatology research: An introduction to a novel OMERACT paradigm.
Journal of Rheumatology.
41:150-152.
2014
|
|
| 2014
|
Increasing obesity and comorbidity in patients undergoing primary total hip arthroplasty in the U.S.: A 13-year study of time trends.
BMC Musculoskeletal Disorders.
15.
2014
|
|
| 2014
|
Introduction: OMERACT 11 - International consensus conference on outcome measures in rheumatology clinical trials.
Journal of Rheumatology.
41:145-149.
2014
|
|
| 2014
|
Methotrexate use and liver disease - A causal relationship?.
British Journal of Dermatology.
171:6-7.
2014
|
|
| 2014
|
OMERACT endorsement of measures of outcome for studies of acute gout.
Journal of Rheumatology.
41:569-573.
2014
|
|
| 2014
|
Outcome measures in acute gout: A systematic literature review.
Journal of Rheumatology.
41:558-568.
2014
|
|
| 2014
|
Reliability and clinically important improvement thresholds for osteoarthritis pain and function scales: A multicenter study.
Journal of Rheumatology.
41:509-515.
2014
|
|
| 2014
|
Remembering the forgotten non-communicable diseases.
BMC Medicine.
12.
2014
|
|
| 2014
|
Research priorities in gout: The patient perspective.
Journal of Rheumatology.
41:615-616.
2014
|
|
| 2014
|
Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis.
Arthritis Care and Research.
66:990-997.
2014
|
|
| 2014
|
Time trends in the characteristics of patients undergoing primary total knee arthroplasty.
Arthritis Care and Research.
66:897-906.
2014
|
|
| 2014
|
Trends in and disparities for acute myocardial infarction: An analysis of Medicare claims data from 1992 to 2010.
BMC Medicine.
12.
2014
|
|
| 2014
|
Updating the OMERACT Filter: Core areas as a basis for defining core outcome sets.
Journal of Rheumatology.
41:994-999.
2014
|
|
| 2014
|
Updating the OMERACT filter: Implications for imaging and soluble biomarkers.
Journal of Rheumatology.
41:1016-1024.
2014
|
|
| 2014
|
Updating the omeract filter: Discrimination and feasibility.
Journal of Rheumatology.
41:1005-1010.
2014
|
|
| 2014
|
Updating the omeract filter: Implications of filter 2.0 to select outcome instruments through assessment of "truth": Content, face, and construct validity.
Journal of Rheumatology.
41:1000-1004.
2014
|
|
| 2013
|
Veterans Affairs databases are accurate for gout-related health care utilization: A validation study.
Arthritis Research and Therapy.
15.
2013
|
|
| 2013
|
Better functional and similar pain outcomes in osteoarthritis compared to rheumatoid arthritis after primary total knee arthroplasty: A cohort study.
Arthritis Care and Research.
65:1936-1941.
2013
|
|
| 2013
|
Folic acid supplementation for rheumatoid arthritis patients on methotrexate: the good gets better.
2013
|
|
| 2013
|
Ofatumumab for rheumatoid arthritis
2013
|
|
| 2013
|
Diabetes: A risk factor for poor functional outcome after total knee arthroplasty.
PLoS One.
8.
2013
|
|
| 2013
|
Participation following knee replacement: The MOST cohort study.
Physical Therapy.
93:1467-1474.
2013
|
|
| 2013
|
Antipsychotics for people with epilepsy and psychosis.
Cochrane Database of Systematic Reviews.
2013.
2013
|
|
| 2013
|
Impact of health education on knowledge and practices about menstruation among adolescent school girls of rural part of district Ambala, Haryana.
Indian Journal of Community Health.
25:492-497.
2013
|
|
| 2013
|
Patients with osteoarthritis and avascular necrosis have better functional outcomes and those with avascular necrosis worse pain outcomes compared to rheumatoid arthritis after primary hip arthroplasty: A cohort study.
BMC Medicine.
11.
2013
|
|
| 2013
|
Total joint replacement surgery versus conservative care for knee osteoarthritis and other non-traumatic diseases
2013
|
|
| 2013
|
Total hip replacement surgery versus conservative care for hip osteoarthritis and other non-traumatic diseases
2013
|
|
| 2013
|
Yield and quality of malt barley (Hordeum vulgare) as influenced by irrigation, nitrogen and methods of sowing.
Indian Journal of Agronomy.
58:354-362.
2013
|
|
| 2013
|
The State of US health, 1990-2010: Burden of diseases, injuries, and risk factors.
Journal of the American Medical Association.
310:591-608.
2013
|
|
| 2013
|
Antidepressants for people with epilepsy and depression
2013
|
|
| 2013
|
Perioperative interventions for smoking cessation in hip and knee arthroplasty for osteoarthritis and other non-traumatic diseases
2013
|
|
| 2013
|
Belimumab for systemic lupus erythematosus
2013
|
|
| 2013
|
Use of botulinum toxin in musculoskeletal pain.
F1000Research.
2.
2013
|
|
| 2013
|
Operative diagnosis for revision total hip arthroplasty is associated with patient-reported outcomes (PROs).
BMC Musculoskeletal Disorders.
14.
2013
|
|
| 2013
|
Sex and surgical outcomes and mortality after primary total knee arthroplasty: A risk-adjusted analysis.
Arthritis Care and Research.
65:1095-1102.
2013
|
|
| 2013
|
Productivity and quality of malt barley (Hordeum vulgare) as affected by sowing date, rate and stage of nitrogen application.
Indian Journal of Agronomy.
58:72-80.
2013
|
|
| 2013
|
The relation between cancer patient treatment decision-making roles and quality of life.
Cancer.
119:2342-2349.
2013
|
|
| 2013
|
Use of biologics in a patient with rheumatoid arthritis refractory to methotrexate.
CMAJ.
185:793-795.
2013
|
|
| 2013
|
Memantine for schizophrenia
2013
|
|
| 2013
|
Ipsilateral lower extremity joint involvement increases the risk of poor pain and function outcomes after hip or knee arthroplasty.
BMC Medicine.
11.
2013
|
|
| 2013
|
The influence of the contralateral knee prior to knee arthroplasty on post-arthroplasty function: The Multicenter Osteoarthritis Study
2013
|
|
| 2013
|
Patient-level clinically meaningful improvements in activities of daily living and pain after total hip arthroplasty: Data from a large US institutional registry.
Rheumatology.
52:1109-1118.
2013
|
|
| 2013
|
Mediation of smoking-associated postoperative mortality by perioperative complications in veterans undergoing elective surgery: Data from Veterans Affairs Surgical Quality Improvement Program (VASQIP)a cohort study.
BMJ Open.
3.
2013
|
|
| 2013
|
Clinically important body weight gain following knee arthroplasty: A five-year comparative cohort study.
Arthritis Care and Research.
65:669-677.
2013
|
|
| 2013
|
Medical and psychological comorbidity predicts poor pain outcomes after total knee arthroplasty.
Rheumatology.
52:916-923.
2013
|
|
| 2013
|
Reply.
Arthritis Care and Research.
65:832-833.
2013
|
|
| 2013
|
Crystal arthritis: Is HLAB genotyping the future of gout pharmacogenomics?.
Nature Reviews Rheumatology.
9:200-202.
2013
|
|
| 2013
|
Gout-related health care utilization in US emergency departments, 2006 through 2008.
Arthritis Care and Research.
65:571-577.
2013
|
|
| 2013
|
Predictors of periprosthetic fracture after total knee replacement: An analysis of 21,723 cases.
Acta Orthopaedica.
84:170-177.
2013
|
|
| 2013
|
Harms of TNF inhibitors in rheumatic diseases: A focused review of the literature.
Immunotherapy.
5:265-299.
2013
|
|
| 2013
|
Income and patient-reported outcomes (PROs) after primary total knee arthroplasty.
BMC Medicine.
11.
2013
|
|
| 2013
|
Racial and gender disparities among patients with gout.
Current Rheumatology Reports.
15.
2013
|
|
| 2013
|
Are Gender, Comorbidity, and Obesity Risk Factors for Postoperative Periprosthetic Fractures After Primary Total Hip Arthroplasty?.
Journal of Arthroplasty.
28.
2013
|
|
| 2013
|
Clinically important body weight gain following total hip arthroplasty: A cohort study with 5-year follow-up.
Osteoarthritis and Cartilage.
21:35-43.
2013
|
|
| 2013
|
Medical comorbidity is associated with persistent index hip pain after total hip arthroplasty.
Pain Medicine.
14:1222-1229.
2013
|
|
| 2013
|
Patient race and surgical outcomes after total knee arthroplasty: an analysis of a large regional database..
Arthritis Care and Research.
65:414-420.
2013
|
|
| 2013
|
Using tablet computers compared to interactive voice response to improve subject recruitment in osteoporosis pragmatic clinical trials: Feasibility, satisfaction, and sample size.
Patient Preference and Adherence.
7:517-523.
2013
|
|
| 2012
|
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
2012
|
|
| 2012
|
Emerging therapies for gout.
Expert Opinion on Emerging Drugs.
17:511-518.
2012
|
|
| 2012
|
Predictors of use of pain medications for persistent knee pain after primary Total Knee Arthroplasty: A cohort study using an institutional joint registry.
Arthritis Research and Therapy.
14.
2012
|
|
| 2012
|
Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States.
Contemporary Clinical Trials.
33:1211-1216.
2012
|
|
| 2012
|
Periprosthetic infections after total shoulder arthroplasty: A 33-year perspective.
Journal of Shoulder and Elbow Surgery.
21:1534-1541.
2012
|
|
| 2012
|
Periprosthetic fractures associated with primary total shoulder arthroplasty and primary humeral head replacement: A thirty-three-year study
2012
|
|
| 2012
|
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis..
Arthritis Care and Research.
64:1447-1461.
2012
|
|
| 2012
|
2012 American college of rheumatology guidelines for management of gout. part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.
Arthritis Care and Research.
64:1431-1446.
2012
|
|
| 2012
|
Periprosthetic infections after shoulder hemiarthroplasty.
Journal of Shoulder and Elbow Surgery.
21:1304-1309.
2012
|
|
| 2012
|
Reply.
Arthritis Care and Research.
64:1623-1624.
2012
|
|
| 2012
|
Total Knee Arthroplasty in Morbidly Obese Patients Treated With Bariatric Surgery. A Comparative Study.
Journal of Arthroplasty.
27:1696-1700.
2012
|
|
| 2012
|
Total knee arthroplasty volume, utilization, and outcomes among medicare beneficiaries, 1991-2010.
Journal of the American Medical Association.
308:1227-1236.
2012
|
|
| 2012
|
Patient Factors Predict Periprosthetic Fractures After Revision Total Hip Arthroplasty.
Journal of Arthroplasty.
27:1507-1512.
2012
|
|
| 2012
|
Peptic ulcer disease and heart disease are associated with periprosthetic fractures after total hip replacement.
Acta Orthopaedica.
83:353-359.
2012
|
|
| 2012
|
Risk factors for revision surgery after humeral head replacement: 1,431 shoulders over 3 decades.
Journal of Shoulder and Elbow Surgery.
21:1039-1044.
2012
|
|
| 2012
|
Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: Evidence from phase III randomized controlled trials.
Journal of Rheumatology.
39:1450-1457.
2012
|
|
| 2012
|
Stem cells and other innovative intra-articular therapies for osteoarthritis: What does the future hold?.
BMC Medicine.
10.
2012
|
|
| 2012
|
Adverse effects of smoking on postoperative outcomes in cancer patients.
Annals of Surgical Oncology.
19:1430-1438.
2012
|
|
| 2012
|
Cardiopulmonary Complications After Primary Shoulder Arthroplasty: A Cohort Study.
Seminars in Arthritis and Rheumatism.
41:689-697.
2012
|
|
| 2012
|
Can racial disparities in optimal gout treatment be reduced? Evidence from a randomized trial.
BMC Medicine.
10.
2012
|
|
| 2012
|
2012 update of the 2008 American college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.
Arthritis Care and Research.
64:625-639.
2012
|
|
| 2012
|
A systematic review of validated methods for identifying orthopedic implant removal and revision using administrative data.
Pharmacoepidemiology and Drug Safety.
21:265-273.
2012
|
|
| 2012
|
Acetylcholinesterase inhibitors for schizophrenia..
Cochrane Database of Systematic Reviews.
1.
2012
|
|
| 2012
|
Developing a provisional definition of flare in patients with established gout.
Arthritis and Rheumatism.
64:1508-1517.
2012
|
|
| 2012
|
Ninety-day Mortality in Patients Undergoing Elective Total Hip or Total Knee Arthroplasty.
Journal of Arthroplasty.
27.
2012
|
|
| 2012
|
Review: Biologic agents increase shortterm risk for some adverse events in conditions other than HIV or AIDS.
ACP journal club.
156.
2012
|
|
| 2012
|
Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update..
Journal of managed care & specialty pharmacy.
18.
2012
|
|
| 2012
|
Systematic Review of Tocilizumab for Rheumatoid Arthritis: A New Biologic Agent Targeting the Interleukin-6 Receptor
2012
|
|
| 2012
|
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
2012
|
|
| 2011
|
Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty.
Annals of the Rheumatic Diseases.
70:2082-2088.
2011
|
|
| 2011
|
The attributable risk of smoking on surgical complications.
Annals of Surgery.
254:914-920.
2011
|
|
| 2011
|
Revision surgery following total shoulder arthroplasty: Analysis of 2588 shoulders over three decades (1976 to 2008).
Bone and Joint Journal.
93 B:1513-1517.
2011
|
|
| 2011
|
Comparison of patient-reported and clinician-assessed outcomes following total knee arthroplasty
2011
|
|
| 2011
|
Ninety day mortality and its predictors after primary shoulder arthroplasty: An analysis of 4,019 patients from 1976-2008.
BMC Musculoskeletal Disorders.
12.
2011
|
|
| 2011
|
Association of peptic ulcer disease and pulmonary disease with risk of periprosthetic fracture after primary total knee arthroplasty.
Arthritis Care and Research.
63:1471-1476.
2011
|
|
| 2011
|
Smoking as a risk factor for short-term outcomes following primary total hip and total knee replacement in veterans.
Arthritis Care and Research.
63:1365-1374.
2011
|
|
| 2011
|
Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis.
Arthritis Research and Therapy.
13.
2011
|
|
| 2011
|
Smoking and outcomes after knee and hip arthroplasty: A systematic review.
Journal of Rheumatology.
38:1824-1834.
2011
|
|
| 2011
|
Therapeutics: Biologicals for rheumatoid arthritis.
British medical journal.
343.
2011
|
|
| 2011
|
Developing a construct to evaluate flares in rheumatoid arthritis: A conceptual report of the OMERACT RA Flare Definition Working Group.
Journal of Rheumatology.
38:1745-1750.
2011
|
|
| 2011
|
Hospital volume and surgical outcomes after elective hip/knee arthroplasty: A risk-adjusted analysis of a large regional database.
Arthritis and Rheumatism.
63:2531-2539.
2011
|
|
| 2011
|
Bringing it all together: A novel approach to the development of response criteria for chronic gout clinical trials.
Journal of Rheumatology.
38:1467-1470.
2011
|
|
| 2011
|
Early postoperative mortality following joint arthroplasty: A systematic review.
Journal of Rheumatology.
38:1507-1513.
2011
|
|
| 2011
|
Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: A randomized controlled trial (The Journal of Rheumatology (2010) 37, (2377-86)).
Journal of Rheumatology.
38:1534.
2011
|
|
| 2011
|
Minimally important differences of the gout impact scale in a randomized controlled trial.
Rheumatology.
50:1331-1336.
2011
|
|
| 2011
|
Patient understanding and satisfaction in informed consent for total knee arthroplasty: A randomized study.
Arthritis Care and Research.
63:1048-1054.
2011
|
|
| 2011
|
Patient-reported outcomes in chronic gout: A report from OMERACT 10.
Journal of Rheumatology.
38:1452-1457.
2011
|
|
| 2011
|
Serum urate in chronic gout - Will it be the first validated soluble biomarker in rheumatology?.
Journal of Rheumatology.
38:1462-1466.
2011
|
|
| 2011
|
Tophus measurement as an outcome measure for clinical trials of chronic gout: Progress and research priorities.
Journal of Rheumatology.
38:1458-1461.
2011
|
|
| 2011
|
Validation of pain and patient global scales in chronic gout: Data from two randomised controlled trials.
Annals of the Rheumatic Diseases.
70:1277-1281.
2011
|
|
| 2011
|
Health Care Utilization in Patients with Gout.
Seminars in Arthritis and Rheumatism.
40:501-511.
2011
|
|
| 2011
|
Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care
2011
|
|
| 2011
|
Responsiveness differences in outcome instruments after revision hip arthroplasty: What are the implications?.
BMC Musculoskeletal Disorders.
12.
2011
|
|
| 2011
|
Surgery for shoulder osteoarthritis: A cochrane systematic review.
Journal of Rheumatology.
38:598-605.
2011
|
|
| 2011
|
Biomarkers in arthroplasty: a systematic review..
Open Orthopaedics Journal.
5:92-105.
2011
|
|
| 2011
|
Diagnosis and management of infected total knee arthroplasty.
Open Orthopaedics Journal.
5:86-91.
2011
|
|
| 2011
|
Epidemiology of knee and hip arthroplasty: a systematic review.
Open Orthopaedics Journal.
5:80-85.
2011
|
|
| 2011
|
Botulinum toxin for shoulder pain: A cochrane systematic review.
Journal of Rheumatology.
38:409-418.
2011
|
|
| 2011
|
Risk factors for gout and prevention: A systematic review of the literature.
Current Opinion in Rheumatology.
23:192-202.
2011
|
|
| 2011
|
Adverse effects of biologics: A network meta-analysis and Cochrane overview.
Cochrane Database of Systematic Reviews.
2011.
2011
|
|
| 2011
|
The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: An international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement.
Osteoarthritis and Cartilage.
19:147-154.
2011
|
|
| 2011
|
Higher Body Mass Index Is Not Associated With Worse Pain Outcomes After Primary or Revision Total Knee Arthroplasty.
Journal of Arthroplasty.
26.
2011
|
|
| 2011
|
Tocilizumab for rheumatoid arthritis: A cochrane systematic review.
Journal of Rheumatology.
38:10-20.
2011
|
|
| 2010
|
Accuracy of VA databases for diagnoses of knee replacement and hip replacement.
Osteoarthritis and Cartilage.
18:1639-1642.
2010
|
|
| 2010
|
Predictors of activity limitation and dependence on walking aids after primary total hip arthroplasty.
Journal of the American Geriatrics Society.
58:2387-2393.
2010
|
|
| 2010
|
Predictors of doctor-rated and patient-rated gout severity: Gout impact scales improve assessment.
Journal of Evaluation in Clinical Practice.
16:1244-1247.
2010
|
|
| 2010
|
Applying science in practice: The optimization of biological therapy in rheumatoid arthritis.
Arthritis Research and Therapy.
12.
2010
|
|
| 2010
|
Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: A randomized controlled trial.
Journal of Rheumatology.
37:2377-2386.
2010
|
|
| 2010
|
Advances in gout: Some answers, more questions.
Arthritis Research and Therapy.
12.
2010
|
|
| 2010
|
A national survey of veterans affairs rheumatologists for relevance of quality of care indicators for gout management.
Arthritis Care and Research.
62:1306-1311.
2010
|
|
| 2010
|
Gout in the Hmong in the United States
2010
|
|
| 2010
|
Preferred roles in treatment decision making among patients with cancer: A pooled analysis of studies using the control preferences scale.
American Journal of Managed Care.
16:688-696.
2010
|
|
| 2010
|
Predictors of pain and use of pain medications following primary Total Hip Arthroplasty (THA): 5,707 THAs at 2-years and 3,289 THAs at 5-years.
BMC Musculoskeletal Disorders.
11.
2010
|
|
| 2010
|
Golimumab for rheumatoid arthritis: A systematic review.
Journal of Rheumatology.
37:1096-1104.
2010
|
|
| 2010
|
Pessimistic explanatory style: A psychological risk factor for poor pain and functional outcomes two years after knee replacement.
Bone and Joint Journal.
92:799-806.
2010
|
|
| 2010
|
Efficacy of Intra-Articular Botulinum Toxin Type A in Painful Knee Osteoarthritis: A Pilot Study
2010
|
|
| 2010
|
Predictors of moderate-severe functional limitation after primary Total Knee Arthroplasty (TKA): 4701 TKAs at 2-years and 2935 TKAs at 5-years.
Osteoarthritis and Cartilage.
18:515-521.
2010
|
|
| 2010
|
Abatacept for rheumatoid arthritis: A cochrane systematic review (Journal of Rheumatology (2010) 37, (234-245) DOI:10.3899/jrheum.091066).
Journal of Rheumatology.
37:682.
2010
|
|
| 2010
|
Newer biological agents in rheumatoid arthritis: Impact on health-related quality of life and productivity.
Drugs.
70:121-145.
2010
|
|
| 2010
|
Trial sample size, but not trial quality, is associated with positive study outcome.
Journal of Clinical Epidemiology.
63:154-162.
2010
|
|
| 2010
|
A population-based study of trends in the use of total hip and total knee arthroplasty, 1969-2008.
Mayo Clinic Proceedings.
85:898-904.
2010
|
|
| 2010
|
Abatacept for rheumatoid arthritis: A cochrane systematic review.
Journal of Rheumatology.
37:234-245.
2010
|
|
| 2010
|
Biologics for rheumatoid arthritis: An overview of Cochrane reviews
2010
|
|
| 2010
|
Botulinum toxin for shoulder pain..
Cochrane Database of Systematic Reviews.
9.
2010
|
|
| 2010
|
Botulinum toxin therapy for osteoarticular pain: An evidence-based review.
Therapeutic Advances in Musculoskeletal Disease.
2:105-118.
2010
|
|
| 2010
|
Challenges with health-related quality of life assessment in arthroplasty patients: Problems and solutions.
Journal of the American Academy of Orthopaedic Surgeons.
18:72-82.
2010
|
|
| 2010
|
Golimumab for rheumatoid arthritis..
Cochrane Database of Systematic Reviews.
2010
|
|
| 2010
|
Pegloticase for chronic gout..
Cochrane Database of Systematic Reviews.
3.
2010
|
|
| 2010
|
Predictors of moderate-severe functional limitation 2 and 5 years after revision total knee arthroplasty.
Journal of Arthroplasty.
25.
2010
|
|
| 2010
|
Surgery for shoulder osteoarthritis..
Cochrane Database of Systematic Reviews.
2010
|
|
| 2010
|
Tocilizumab for rheumatoid arthritis..
Cochrane Database of Systematic Reviews.
7.
2010
|
|
| 2009
|
Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty.
Clinical Rheumatology.
28:1419-1430.
2009
|
|
| 2009
|
Assessment of the methodologic quality of medical and surgical clinical trials in patients with arthroplasty.
Journal of Rheumatology.
36:2642-2654.
2009
|
|
| 2009
|
Biologics for rheumatoid arthritis: an overview of Cochrane reviews..
Cochrane Database of Systematic Reviews.
2009
|
|
| 2009
|
Surgery for shoulder osteoarthritis
2009
|
|
| 2009
|
Use of "spydergrams" to present and interpret SF-36 health-related quality of life data across rheumatic diseases.
Annals of the Rheumatic Diseases.
68:1800-1804.
2009
|
|
| 2009
|
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: A Cochrane overview.
CMAJ.
181:787-796.
2009
|
|
| 2009
|
Intra-articular Botulinum Toxin Type A: A new approach to treat arthritis joint pain.
Toxicon.
54:658-667.
2009
|
|
| 2009
|
Acetylcholinesterase inhibitors for schizophrenia
2009
|
|
| 2009
|
Discordance between self-report of physician diagnosis and administrative database diagnosis of arthritis and its predictors.
Journal of Rheumatology.
36:2000-2008.
2009
|
|
| 2009
|
Mobile and fixed-bearing (all-polyethylene tibial component) total knee arthroplasty designs: A prospective randomized trial
2009
|
|
| 2009
|
Intrapericardial teratoma presenting as recurrent pericardial tamponade: Report of a case.
Surgery Today.
39:700-704.
2009
|
|
| 2009
|
Opportunities for improving medication use and monitoring in gout.
Annals of the Rheumatic Diseases.
68:1265-1270.
2009
|
|
| 2009
|
Anakinra for rheumatoid arthritis: A systematic review.
Journal of Rheumatology.
36:1118-1125.
2009
|
|
| 2009
|
The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes.
Twin Research and Human Genetics.
12:301-311.
2009
|
|
| 2009
|
Effect of resistance exercise on bone mineral density in premenopausal women.
Revue du Rhumatisme.
76:439-447.
2009
|
|
| 2009
|
Effect of resistance exercise on bone mineral density in premenopausal women.
Joint Bone Spine.
76:273-280.
2009
|
|
| 2009
|
Spondyloarthritis is associated with poor function and physical health-related quality of life.
Journal of Rheumatology.
36:1012-1020.
2009
|
|
| 2009
|
Perceptions of disease and health-related quality of life among patients with gout.
Rheumatology.
48:582-586.
2009
|
|
| 2009
|
Toward a Valid Definition of Gout Flare: Results of Consensus Exercises Using Delphi Methodology and Cognitive Mapping.
Arthritis and Rheumatism.
61:535-543.
2009
|
|
| 2009
|
Quality of life and quality of care for patients with gout.
Current Rheumatology Reports.
11:154-160.
2009
|
|
| 2009
|
Health care utilization in patients with spondyloarthropathies.
Rheumatology.
48:272-276.
2009
|
|
| 2009
|
Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: A report of two cases.
Joint Bone Spine.
76:190-194.
2009
|
|
| 2009
|
Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: Two cases.
Revue du Rhumatisme.
76:292-296.
2009
|
|
| 2009
|
Can patients help with long-term total knee arthroplasty surveillance? Comparison of the American Knee Society Score self-report and surgeon assessment.
Rheumatology.
48:160-164.
2009
|
|
| 2009
|
Abatacept for rheumatoid arthritis..
Cochrane Database of Systematic Reviews.
2009
|
|
| 2009
|
Accuracy of veterans affairs databases for diagnoses of chronic diseases
2009
|
|
| 2009
|
Anakinra for rheumatoid arthritis.
Cochrane Database of Systematic Reviews.
2009
|
|
| 2009
|
Biologics for rheumatoid arthritis: An overview of Cochrane reviews
2009
|
|
| 2009
|
Editorial: Health care costs in gout: What are these emerging data telling us?
2009
|
|
| 2009
|
Effect of comorbidity on quality of life of male veterans with prevalent primary total knee arthroplasty..
Clinical Rheumatology.
28:1083-1089.
2009
|
|
| 2009
|
Higher comorbidity, poor functional status and higher health care utilization in veterans with prevalent total knee arthroplasty or total hip arthroplasty..
Clinical Rheumatology.
28:1025-1033.
2009
|
|
| 2009
|
Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial
2009
|
|
| 2009
|
Repeat injections of intra-articular botulinum toxin a for the treatment of chronic arthritis joint pain
2009
|
|
| 2008
|
Evaluation of an instrument assessing influence of gout on health-related quality of life.
Journal of Rheumatology.
35:2406-2414.
2008
|
|
| 2008
|
Health-related quality of life in veterans with prevalent total knee arthroplasty and total hip arthroplasty.
Rheumatology.
47:1826-1831.
2008
|
|
| 2008
|
Abatacept for rheumatoid arthritis
2008
|
|
| 2008
|
Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans.
Annals of the Rheumatic Diseases.
67:1310-1316.
2008
|
|
| 2008
|
A rare cause of hypertension in children: Intrathoracic pheochromocytoma.
Pediatric Surgery International.
24:865-867.
2008
|
|
| 2008
|
A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout.
Annals of the Rheumatic Diseases.
67:888-891.
2008
|
|
| 2008
|
Anakinra for rheumatoid arthritis
2008
|
|
| 2008
|
Chronic constrictive calcific pericarditis.
Asian Cardiovascular and Thoracic Annals.
16:432-433.
2008
|
|
| 2008
|
Surgical management of aortic stenosis in a child.
Medical Journal Armed Forces India.
64:197-198.
2008
|
|
| 2007
|
Assessment of outcome in clinical trials of gout - A review of current measures.
Rheumatology.
46:1751-1756.
2007
|
|
| 2007
|
Improved health-related quality of life with effective disease-modifying antirheumatic drugs: Evidence from randomized controlled trials.
American Journal of Managed Care.
13.
2007
|
|
| 2007
|
Absence of histologic evidence of synovitis in patients with Gulf War veterans' illness with joint pain.
Arthritis and Rheumatism.
57:1316-1323.
2007
|
|
| 2007
|
Classification criteria in rheumatic diseases: A review of methodologie properties.
Arthritis and Rheumatism.
57:1119-1133.
2007
|
|
| 2007
|
The effects of intra-articular botulinum toxin on sacroiliac, cervical/lumbar facet and sternoclavicular joint pain and C-2 root and lumbar disc pain: A case series of 11 patients.
Pain Clinic.
19:27-32.
2007
|
|
| 2007
|
Effect of health-related quality of life on women and men's veterans affairs (VA) health care utilization and mortality.
Journal of General Internal Medicine.
22:1260-1267.
2007
|
|
| 2007
|
Quality of care for gout in the US needs improvement.
Arthritis and Rheumatism.
57:822-829.
2007
|
|
| 2007
|
Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases.
Arthritis and Rheumatism.
57:648-655.
2007
|
|
| 2007
|
Contributions of OMERACT to rheumatic disease research [1].
Arthritis and Rheumatism.
57:186.
2007
|
|
| 2006
|
Long term effects of intra-articular botulinum toxin a for refractory joint pain.
Neurotoxicity Research.
9:179-188.
2006
|
|
| 2006
|
Spondyloarthropathy: An independent risk factor for kidney stones
2006
|
|
| 2006
|
Antibiotics for reactive arthritis
2006
|
|
| 2006
|
Management of Superior Vena Cava Syndrome by Internal Jugular to Femoral Vein Bypass.
Annals of Thoracic Surgery.
82:310-312.
2006
|
|
| 2006
|
Development of classification and response criteria for rheumatic diseases.
Arthritis and Rheumatism.
55:348-352.
2006
|
|
| 2006
|
Use of breath carbon monoxide measurements to assess erythrocyte survival in subjets with chronic diseases.
American Journal of Hematology.
81:432-438.
2006
|
|
| 2006
|
Left ventricule rupture after mitral valve replacement [1].
Asian Cardiovascular and Thoracic Annals.
14:537.
2006
|
|
| 2005
|
Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: A preliminary report.
Lupus.
14:137-144.
2005
|
|
| 2005
|
Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: The veterans arthritis quality of life study.
Seminars in Arthritis and Rheumatism.
34:755-765.
2005
|
|
| 2005
|
Health-related quality of life, functional impairment, and healthcare utilization by veterans: Veterans' quality of life study.
Journal of the American Geriatrics Society.
53:108-113.
2005
|
|
| 2005
|
Opioid use by patients in an orthopedics spine clinic.
Arthritis and Rheumatism.
52:312-321.
2005
|
|
| 2004
|
Accuracy of veterans administration databases for a diagnosis of rheumatoid arthritis.
Arthritis and Rheumatism.
51:952-957.
2004
|
|
| 2004
|
Immunohistochemistry of normal synovium [2] (multiple letters).
Annals of the Rheumatic Diseases.
63:1532-1533.
2004
|
|
| 2004
|
Immunohistochemistry of normal human knee synovium: A quantitative study.
Annals of the Rheumatic Diseases.
63:785-790.
2004
|
|
| 2004
|
Quantitative analysis of immunohistologic features of very early rheumatoid synovitis in disease modifying antirheumatic drug- and corticosteroid- naïve patients.
Journal of Rheumatology.
31:1281-1285.
2004
|
|
| 2003
|
Leflunomide Use during the First 33 Months after Food and Drug Administration Approval: Experience with a National Cohort of 3,325 Patients.
Arthritis and Rheumatism.
49:745-751.
2003
|
|
| 2003
|
Talo-patello-scaphoid osteolysis, synovitis, and short fourth metacarpals in sisters: A new syndrome?.
American Journal of Medical Genetics Part A.
121 A:118-125.
2003
|
|
| 2003
|
Talo-patello-scaphoid osteolysis, synovitis, and short fourth metacarpals in sisters: a new syndrome?.
American Journal of Medical Genetics Part A.
121A:118-125.
2003
|
|
| 2002
|
Ciprofloxacin-related acute peripheral neuropathy in a patient with lupus nephritis
2002
|
|
